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Abstract  
Asthma, defined as a complex, chronic inflammatory disease of the airways, affects 
approximately 300 million individuals worldwide and is the single most common chronic 
disease among children.  Airway inflammation is the defining characteristic of asthmatic 
pathophysiology; and as asthma increases in severity, the airways become more susceptible 
to environmental insults, including air pollutants. Wildfires and prescribed burns are 
significant sources of airborne particles, as well as gaseous pollution, which can 
temporarily increase the overall levels of air pollution over hundreds or thousands of square 
miles. Multi-walled carbon nanotubes (MWCNT) are increasingly used in a broad range 
of applications, including medical treatments, construction in the aerospace industry, and 
electronics manufacture. Accordingly, the following studies were conducted to narrow the 
gaps in existing knowledge of the health hazards posed by wood smoke (WS) and inhaled 
MWCNT. To model allergic asthma, the most common form of the disease, we introduced 
house dust mite (HDM) allergen, an allergy trigger for almost 85% of asthmatics. We found 
that adult C57BL/6 mice previously sensitized to HDM displayed significantly exacerbated 
lung inflammation following oropharyngeal MWCNT instillation. This was characterized 
by elevated levels of EPO and correspondingly increased eosinophil populations, measured 
by flow cytometry, in the BALF. Th2-associated cytokines traditionally implicated in 
allergic asthma, such as IL-13 and IL-22, were notably lacking; likewise, no clear alteration 
in CD4+ or CD8+ T cells was found.  Instead, a significant increase in levels of cysteinyl 
leukotrienes (cys-LT) was detected, which correlated to increases in eosinophilia. This 
coincidence of augmented eosinophil recruitment and increased cys-LT production was 
again observed in our study of WS exposure. Adult female mice exposed to WS while 
pregnant displayed markedly increased eosinophilia when later sensitized to HDM, as 
evidenced by EPO levels and quantification via flow cytometry, as well as elevated cys-
LT levels. Interestingly, the offspring of those WS-exposed mice, when sensitized to HDM 
in adulthood, responded with dramatically exacerbated inflammation in the same mode. 
H&E and PAS staining revealed mucus deposition and marked cellular infiltration in the 
lungs of prenatally exposed offspring following HDM challenge. Pups displayed highly 
significant differences in EPO levels between WS/HDM and Air/HDM groups at 8 weeks 
of age; eosinophilia decreased over time, with these differences remaining significant at 16 
weeks and being lost by 24 weeks. The numbers of CD4+ and CD8+ T cells were also 
affected: in dams, WS inflated these populations and HDM decreased them; in pups, the 
opposite was true. These findings indicate a direct relationship between the biosynthesis of 
cys-LT and the recruitment of eosinophils in response to MWCNT inhalation, and suggest 
that a similar mechanism—likely with a greater T cell component—may be responsible for 
the inflammation arising from exposure to WS.  
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1.0 An Introduction to Allergic Asthma 
 Asthma is commonly defined as a complex, chronic inflammatory disease of the 
airways.  It affects approximately 300 million individuals worldwide, including 1-5% of 
adults in Asia and 10% in Australia, and is the single most common chronic disease among 
children (1-4).  It has been more formally defined by the Global Initiative for Asthma 
(GINA): “Asthma is a heterogeneous disease, usually characterized by chronic airway 
inflammation. It is defined by a history of respiratory symptoms such as wheeze, shortness 
of breath, chest tightness and cough that vary over time and in intensity, together with 
variable expiratory airflow limitation” (5).  This definition takes into account not only the 
classical pathologies of asthma, but also the existence of many phenotypes. The root causes 
of asthma are varied and incompletely understood, at best; they are believed to include 
genetic predisposition—derived from over 100 possible susceptibility genes—and 
numerous environmental factors, and this variability results in high individualization from 
patient to patient.  The major disease forms include allergic asthma, steroid-resistant 
asthma, and asthma induced by exposure to airborne irritants such as cigarette smoke and 
diesel exhaust (2).  The most common of these is allergic asthma (6). However, all types 
of asthma share a degree of overlap in symptoms and triggers and must to some extent be 
considered in connection rather than isolation. Accordingly, the studies discussed in this 
text will focus on the inflammatory processes of allergic asthma: particularly, the ways in 
which those processes may be impacted by inhaled particulate pollution. 
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1.1 Characteristics of Asthma 
Allergic asthma is primarily a disorder of the conducting airways which leads to 
airway hyperreactivity (AHR) and variable airflow obstruction (7).  Airway inflammation 
is the defining characteristic of asthmatic pathophysiology; this stems from the release of 
inflammatory mediators and resultant remodeling of the airway wall.  Therefore, as asthma 
increases in severity, the airway becomes more susceptible to environmental insults, 
including air pollutants.  The airway repair response is also altered, with abnormal secretion 
of growth factors that induce mucus cell, smooth muscle, and nerve cell proliferation; 
angiogenesis; and fibrosis.  Variations in each of these symptoms account for the myriad 
asthmatic phenotypes and their differing responses to conventional treatment (7). 
Allergic asthma is believed to derive from childhood exposure and sensitization to 
aeroallergens such as those derived from house dust mites (HDM), cockroaches, animal 
dander, fungi, and pollens.  This usually occurs through selective expansion of T-helper 
type 2 (Th2) cells (7).  Indeed, data from adoptive-transfer studies have revealed that Th2 
cells alone are sufficient to elicit the major characteristics of asthma (8), although in reality 
they are supported by other cell types.  Phosphorylation of the transcription factor GATA-
3 activates CD4+ Th2 cells, which produce a number of cytokines, including interleukins 
4, 5, 9, and 13, and GM-CSF (7).  These cytokines in turn initiate a cascade of inflammatory 
mechanisms: isotype switching by B cells to produce immunoglobulin E (IgE) depends on 
IL-4 and IL-13; IgE crosslinking activates mast cell production of IL-3, 4, 5, and 13; the 
recruitment of eosinophils to the airways, maturation, and survival are mediated by IL-3, 
IL-5, and GM-CSF; the recruitment of basophils relies on IL-3 and GM-CSF; and the 
survival of Th2 cells themselves requires IL-4 (2, 4, 7).    
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Eosinophils and type 2 innate lymphoid cells (ILC2s) are also capable of making 
some of the cytokines commonly associated with the Th2 response, including Il-4, IL-5, 
and IL-13.  Additionally, other cytokines, including IL-17 and IL-22, are often detected in 
both human asthmatics and murine models; and some human patients display 
predominantly neutrophilic rather than eosinophilic inflammation.  Thus, though Th2 cells 
and associated cytokines are fundamental components of asthma in many instances, it is 
also important to consider that the classic paradigm of Th2-driven inflammation does not 
present a complete picture of this disease (8). 
 
1.1.1 Characteristics of Asthma: Airway Hyperreactivity 
AHR describes the tendency of airways to respond disproportionately to 
nonspecific stimuli, e.g., exercise or abrupt temperature change (8).  The mechanisms 
underlying AHR in asthma are complex, but are at least partially dependent on the presence 
of the Th2-associated inflammatory cytokines.  IL-9 and IL-13 are known to be important 
to the progression of AHR; mice deficient in these display impaired development of AHR 
and lung eosinophilia (4, 9).  Related inflammatory cells are, of course, also crucial.  It has 
been reported that AHR depends on the recruitment of eosinophils to the bronchial 
submucosa: blockage of MCP-5, monocytic chemoattractant protein 5, a chemokine which 
affects eosinophilia in the interstitium but not in the airways, decreases AHR (10).  In an 
OVA-based murine model of asthma, antibody neutralization of a stimulated T-cell 
chemotactic protein (STCP-1), MDC, was shown to prevent the development of AHR.  
MDC is a potent chemoattractant when bound to the chemokine receptor CCR4; in the 
mouse, MDC is produced by alveolar macrophages and smooth muscle cells and is 
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responsible for the recruitment of monocytes and activated T cells and Th2 cells (10), 
indicating that AHR relies on more than eosinophilia alone.  Nitric oxide signaling has also 
been implicated in the regulation of AHR in asthma (9).  Measuring FeNO (fractional 
exhaled nitric oxide) in exhaled breath is a simple, non-invasive way to identify IL-13-
driven inflammation (11).  Release of IL-13 in the airways results in the activation of 
inducible nitric oxide synthase and therefore increased levels of NO; because of this, 
asthmatic patients typically exhale higher levels of nitric oxide than do non-asthmatics (9, 
11).  This may be connected to the activity of S-nitrosoglutathione, or GSNO.  An 
endogenous bronchodilator, GSNO would naturally counteract the bronchoconstriction 
observed in asthma.  However, levels of GSNO are decreased in asthmatic patients; this is 
believed to directly impact the progression of AHR, as the addition of GSNO reductase has 
been shown to protect against hyperreactivity (9). 
 
1.1.2 Characteristics of Asthma: Airway Remodeling 
Airway remodeling is often defined broadly so as to encompass any alteration in 
composition, distribution, thickness, mass, volume, and/or structure of the airway wall. 
These alterations include: changes to the airway epithelium, such as epithelial shedding, 
goblet cell hyperplasia, and basal membrane thickening; subepithelial fibrosis of 
peribronchial interstitial tissue; hyperplasia or hypertrophy of airway smooth muscle cells; 
increased neurite sprouting; and alterations of the bronchial vasculature, such as barrier 
dysfunction and angiogenesis. These symptoms can be separated into two categories: 
physiological and pathological. Physiological remodeling encompasses any structural 
change of the sort which occurs during normal lung development, growth, or healing after 
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acute injury or short-term inflammation. Pathological remodeling includes any structural 
change that occurs due to abnormal development or chronic inflammation or injury and 
results in persistent alteration to lung function (5). 
 
1.1.3 Characteristics of Asthma: Cellular Inflammation 
Eosinophils: Eosinophils play a pivotal role in a number of allergic inflammatory 
processes, including those underlying asthma (12).  Indeed, the presence of eosinophils in 
the airways of those suffering from allergic asthma has been well documented (13, 14) and 
is commonly used as a biomarker of the disease during diagnosis (15). It has been proposed 
that the presence of infiltrating inflammatory cells, particularly CD4+ T cells and 
eosinophils, should be considered the defining characteristic of airway remodeling in 
asthma (5, 13).  
The eosinophil has been implicated in host resistance to parasites, particularly 
helminthes, as well as in antimicrobial activities against bacterial, viral, and protozoan 
pathogens; they have also been identified as mediators of hypersensitivity diseases (12).  
Eosinophils are granulocytes derived from multipotent hematopoietic stem cells in the bone 
marrow.  Development from these precursors is dependent on certain growth factors and 
cytokines, particularly IL-3, IL-5, and GM-CSF (16, 17). Of these, IL-5 is the cytokine 
most specifically targeted to eosinophil maturation (18).  In the presence of high systemic 
levels of IL-5, mice display depletion of bone marrow eosinophils and a corresponding 
increase in circulating eosinophils, suggesting that the release of these cells from the bone 
marrow into the blood is stimulated by IL-5.  Further, mice engineered to overexpress IL-
5 show pronounced eosinophilia in the blood, spleen, and bone marrow (16, 18), while IL-
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5 deficiency prevents eosinophilia, and mice engineered to be deficient in eosinophils 
themselves show stunted airway remodeling (8). 
 
Fig. 1.1: Factors responsible or possibly responsible for the survival of eosinophils in 
inflamed airways, including IL-3, IL-5, and GM-CSF.  (Adapted from (19).) 
 
Eosinophils produce a variety of cytokines and growth factors.  These are released 
in small amounts while eosinophils are in a resting state, and they are induced in greater 
volume during inflammatory conditions. Stimulation by eosinophilic recognition of 
cytokines, immunoglobulins, or complement can induce the secretion of proinflammatory 
cytokines including: IL-2, IL-4, IL-5, IL-10, IL-12, IL-13, IL-16, IL-18, TGF-α, and TGF-
β; chemokines such as RANTES and eotaxin-1; and lipid mediators, such as platelet 
activating factor and the cysteinyl leukotriene LTC4 (14, 16).  
As granulocytes, eosinophils are able to secrete an array of cytotoxic proteins.  
These include EPO, or eosinophil peroxidase, which is an important experimental marker 
of eosinophil activity.  EPO is localized to the granule matrix and makes up roughly 25% 
of an individual granule’s protein mass.  EPO is an enzyme used to catalyze the oxidation 
of halides, pseudohalides, and nitric oxide to form reactive oxygen and nitrogen species.  
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These then oxidize nucleophilic targets, thereby promoting oxidative stress and cell death 
via apoptosis or necrosis (16). 
 
Airway Epithelial Cells: The Innate Immune Response (IIR) is a rapid, non-pathogen-
specific intracellular inflammatory response produced by detection of a pathogen signature 
by sentinel airway cells that patrol for non-self antigens (6).  These sentinels include airway 
epithelial cells, alveolar macrophages, and dendritic cells (DCs) acting as specialized 
antigen-presenting cells (APCs).  With IIR activated, a host of immune cells undergo 
induced changes resulting in phenotypes which favor the production of inflammatory 
cytokines and protective mucosal interferons.  These factors contain the spread of any 
pathogens and regulate the magnitude of ensuing adaptive immune activity (6). 
Sentinel cells use pattern recognition receptors (PRRs) to identify pathogen-
associated molecular patterns (PAMPs), such as dsRNA, lipoteichoic acids, mannans, or 
flagellins (6).  PRRs can be divided into two major classes: membrane-resident Toll-like 
receptors (TLRs) and cytoplasmic Retinoic Acid inducible Gene (RIG)-I-like RNA 
helicases (RLHs).  RLHs are most useful in the detection of invading dsRNA within cells, 
whereas TLRs are surface-localized and able to bind diverse PAMPs, including the asthma 
trigger LPS (6). 
The current body of evidence indicates a major role for epithelial cells in initiating 
and sustaining pulmonary IIR. Epithelial cells produce CC, CXC, and C-class chemokines, 
which trigger acute inflammation.  CXC chemokines are involved in the recruitment of 
leukocytes to the interstitial spaces and airway lumen, from whence activated leukocytes 
can then migrate to the site of infection and induce phagocytosis and antigen uptake (6). 
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Several types of lymphoid cells, including eosinophils, basophils, and mast cells, 
are recruited to affected airways immediately after allergen challenge.  These generate 
inflammatory mediators, such as histamines, cysteinyl leukotrienes, and proinflammatory 
cytokines IL-4, 5, 10, 13 and tumor necrosis factor (TNF) (2).  
 
 
Fig. 1.2: Pathways of innate immunity involved in allergic asthma.  IL-25, IL-33, and 
TSLP induce Th2-associated cytokine production by “natural helper cells,” now known as 
ILC2 cells, in the absence of Th2 cells.  NKT cells are stimulated to produce IL-13, thereby 
promoting AHR and airway remodeling.  (Adapted from (2).) 
 
CD4+ T cells:  The involvement of CD4+ T helper cells in allergic asthma has been well-
documented (20-25). T helper cells differentiate into distinct subsets based on their 
microenvironment and cellular interactions; these phenotypes include Th1, Th2, and Th17, 
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which are distinguished by their differing immune functions and cytokine production.  Th1 
cells produce IFNγ and mediate cellular immunity; Th2 cells produce IL-4, IL-5, and IL-
13, which mediate humoral immunity, immunoglobulin production by B cells, and allergic 
responses.  Th17 cells produce IL-17 and have been associated with chronic inflammation.  
Through these processes, IIR induces not only acute inflammation but also Th polarization 
and sensitization in the airways (6). 
 
 
Fig. 1.3: An overview of the type-2 inflammatory response to allergens.  Th2-associated 
cytokines produced by ILC2 or Th2 cells drive IgE switching in B cells and recruitment of 
effector cells such as eosinophils, which promote the hallmark characteristics of allergic 




Maturation of a naïve T helper cell, dubbed Th0, is prompted by recognition of an 
antigen by an APC (e.g., a dendritic cell), which presents that antigen to the Th0 cell. At 
that point, the Th0 may differentiate into any one of a number of possible phenotypes. The 
phenotype most commonly associated with allergic asthma is the Th2 cell (23). Precisely 
what process drives differentiation from Th0 to Th2 remains unclear; but it has been shown 
that IL-4, possibly produced by mast cells or basophils, is necessary to activate STAT6 
(signal transducer and activator of transcription 6) and GATA-3 (GATA-binding protein 
3) (7). When expressed by activated Th2 cells, these transcription factors regulate the 
production of several proinflammatory cytokines (26). These are IL-4, which regulates the 
synthesis of allergen-specific IgE; IL-5, which mediates the recruitment of eosinophils; IL-
9, which stimulates the growth and recruitment of mast cells; and IL-13, which promotes 
AHR and mucus production (23).  
   
Dendritic Cells: Another cell type that is crucial to mediation of airway inflammation is 
the dendritic cell. It is believed that immature monocytes are recruited to the lung through 
the action of the chemokine receptors CCR2 and CCR6 and CCL20-MIP-1α signaling 
arising from IIR activation (27). Mature DCs coordinate the development of adaptive 
immunity from the acute inflammatory response, in part by inducing Th2 activation (27, 
28). The sources of this ability are twofold. Firstly, DC maturation is enhanced by the 
presence of epithelial-derived thymic stromal lymphopoietin (TSLP) and granulocyte-
macrophage colony stimulating factor (GM-CSF), both of which are IIR-inducible 
cytokine-like molecules produced by lung epithelial cells (27). Secondly, matured DCs 
express an array of PRRs, TLRs, NOD (nucleotide-binding oligomerization domain)-like 
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receptors, and C-type lectin receptors, which collectively enable these cells to recognize 
numerous allergens and present them to T cells (28).  
 
Innate Lymphoid Cells: ILCs are non-T, non-B effector cells that show high levels of 
cytokine production following activation (29).  They were first identified in the intestine 
and have since been found in the lung as well.  ILCs are involved in tissue homeostasis, 
repair and remodeling, and immunity.  Due to their lack of T- and B-cell receptors, ILCs 
are antigen nonspecific and react rapidly to a vast range of innate signals.  These cells have 
been classified into three distinct subsets based on their cytokine profiles: ILC1, ILC2, and 
ILC3.  All of these subsets share a common progenitor, identified as Lin-IL-
7Rα+KitlowScalow; and all ILCs require IL-7 signaling and the action of Id2, a transcriptional 
repressor that regulates Notch signaling, for proper development (29).  Of these subsets, 
ILC2s are particularly important in the context of asthma. 
 
Fig. 1.4: The function of innate 
lymphoid cells in the development of 
asthma. An inflammatory stimulus, 
such as HDM allergen, prompts airway 
epithelial cells to release cytokines that 
influence the differentiation of ILC 
subsets.  Activated ILC1, 2, and 3 
produce an assortment of cytokines 
	 12	
capable of activating other immune cells downstream and intensifying asthmatic 
symptoms. (Adapted from (29).) 
 
Th2 cells are a major source of some of the cytokines most closely associated with 
the symptoms of allergic asthma.  However, the notion that Th2s are essential to asthmatic 
development was challenged by the observation that mice lacking a functional adaptive 
immune system, e.g., Rag1-/- mice, nonetheless mount a strong type 2 response to 
inflammatory stimuli (4).  This can be attributed to the activity of ILC2s.  Although they 
lack the specific antigen receptor of Th2 cells, ILC2s are fully capable of producing the 
type 2 cytokines critical to asthmatic development (4, 30, 31).  ILC2s are now regarded as 
a key source of such cytokines during the earliest stages of allergic response before Th2 
cells are recruited to the site of inflammation (30). 
ILC2s can impact both innate and adaptive immune processes in asthma.  It has 
been demonstrated that pulmonary ILC2s are capable of significant IL-5 and IL-13 
production following stimulation with inhaled allergens, including HDM.  IL-5+ and IL-
13+ populations of ILC2s have even been measured at levels comparable to IL-5+ and IL-






Fig. 1.5: Interactions of ILC2s with their environment.  Proinflammatory cytokines 
produced by ILC2s echo those made by Th2s, including IL-4, IL-5, and IL-13.  Treg cells 
are able to exert a suppressive influence through inducible T cell co-stimulator (ICOS).  
(Adapted from (31).) 
 
While the precise mechanisms of ILC2 activation remain somewhat unclear, it does 
appear that much like Th2s, ILC2s can be activated by a variety of epithelial-derived 
cytokines, including IL-25, IL-33, and TSLP (4, 30).  ILC2s have further been shown to 
rely on at least some of the same transcription factors as Th2s, including RORα and 
GATA3 (30, 31).  Prostaglandins and leukotrienes have also been reported to activate 




1.1.4 Characteristics of Asthma: Production of Cysteinyl Leukotrienes 
Cysteinyl leukotrienes (cys-LT) are small, peptide-conjugated lipids derived from 
arachidonic acid.  They are potent mediators of inflammation throughout the body and are 
demonstrably important in the pathogenesis of asthma (32, 33).  Oxygenation of 
arachidonic acid by 5-lipoxygenase (5-LO), chaperoned by 5-lipoxygenase-activating 
protein (FLAP), yields leukotriene A4 (LTA4). LTA4 is then hydrolyzed to form the 
dihydroxy leukotriene B4 (LTB4) and the cysteinyl leukotrienes C4, D4, and E4 (33).  LTB4 
interacts with its major receptor, BLT1, to promote the recruitment of inflammatory cells.  
Cys-LT produce similar effects: by acting upon types 1 and 2 cysteinyl leukotriene 
receptors (CysLT1, CysLT2) and g-protein-coupled-receptor 99 (GPR99), they activate 
various kinase cascades (34, 35).   
Cells involved in the acute inflammatory response, including macrophages, secrete 
cys-LT to recruit eosinophils and other leukocytes to sites of infection (36).  Some, if not 
all, of these cell populations—notably eosinophils and alveolar macrophages—display 
increased biosynthesis of cys-LT in asthmatic patients compared to healthy individuals 
(32).  Through the action of CysLT1, cys-LT induce the classic symptoms of asthma: 
bronchoconstriction, tissue swelling, and increased mucus secretion. Activation of CysLT2 
mediates inflammation, vascular permeability, and fibrosis (37). Furthermore, mice with 
experimental fibrosis and human patients with idiopathic pulmonary fibrosis show 
increased cys-LT in their lungs.  Cys-LT can also stimulate fibroblasts to multiply and 
produce the collagen used in fibrotic remodeling. Importantly, inhibition of cys-LT activity 
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has been shown to decrease both acute inflammation and the development of fibrosis (36). 
Cysteinyl leukotrienes can be produced in the lung by mast cells, basophils, 
alveolar macrophages, dendritic cells, and pulmonary eosinophils; all of these cell types 
constitutively express the enzymes necessary to synthesize LTC4 from LTA4.  Expression 
of CysLT1 and CysLT2 at both the mRNA and protein levels can be modulated by Th1 
and Th2-associated cytokines such as IL-4, IL-5, IL-13, TGF-β, and IFNγ (35).  It has 
previously been shown that airway epithelial cells upregulate expression of these enzymes, 
i.e., 5-lipoxygenase and LTC4 synthase, in response to lipopolysaccharide.  LTC4 is made 
rapidly in response to cellular activation and is then excreted and converted into LTD4 and 
LTE4 outside the origin cell (38).  LTE4 is the most stable of the cys-LT and thus the most 
abundant.  It is also the most potent leukotriene in in vivo systems, highly effective in 
eliciting eosinophilia, basophilia, and muscular constriction in asthmatic bronchii as well 
as in increasing airway sensitivity to histamine and vascular permeability (33, 39).  LTE4 
produces these effects by binding to the recently-discovered GPR99, which is commonly 
expressed by nonhematopoietic cells and binds LTE4 more strongly than either CysLT1 or 
CysLT2 (35).  Direct inhalation of cys-LT, particularly LTE4, induces heightened 
bronchoconstriction in asthmatic individuals compared to healthy ones (39).  
Accordingly, disruption of cys-LT signaling appears to have a protective effect 
against related asthmatic symptoms. Mice deficient in LTC4 synthase or CysLT1 are 
incapable of synthesizing or recognizing cys-LT, respectively.  Both mouse strains display 
significantly impaired eosinophilic inflammation and Th2 responses following exposure to 
HDM (38). Furthermore, compounds formulated to inhibit the oxidation of 5-LO have 
proved as effective as selective receptor antagonists, and both classes of drugs are effective 
	 16	
in improving airflow in asthmatic patients and reducing the frequency of asthma attacks 
(38). 
   
1.2 Modeling Allergic Asthma in Mice 
1.2.1 House Dust Mite  
Mites of the genus Dermatophagoides, particularly the pteronyssinus and farinae 
species, preferentially colonize human habitats and can thus be found in homes around the 
world.  Perhaps as a result of their ubiquitous presence, house dust mites (HDM) pose a 
significant allergic hazard; it is estimated that one to two percent of the global population 
is allergic to HDM (40). Exposure can cause rhinitis, conjunctivitis, and dermatitis.  HDM 
allergens are also potent activators of asthma, and 50-85% of asthmatics are allergic to 
HDM (1).    
Both D. pteronyssinus and farinae live for approximately ten weeks, requiring three 
to four weeks to reach reproductive maturity.  During the four to six remaining weeks of 
their lifespan, female mites lay between 40 and 80 eggs each; the resulting population boom 
enables HDM to colonize the entirety of a house within a single year.  Human habitats are 
particularly beneficial for HDM because they provide ample supplies of organic debris.  
Keratin can be derived from sloughed human skin, cellulose from textiles, and chitin from 
fungi and mite carcasses.  Keratin is the house dust mite’s primary food source, although 
the mites also eat bacteria, pollen, and fungal mycelia.  As part of the digestive process, 
these food particles are bound to dissociated cells from the gut wall; the digestive enzymes 
contained in these cells are a major source of HDM allergenicity (40). 
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 Allergy to HDM involves both the mites themselves and their waste.  The mites’ 
exoskeletons are composed of the structural polysaccharide chitin, which is a potent 
adjuvant capable of regulating both innate and adaptive immune responses.  Chitin causes 
eosinophils and basophils to accumulate and stimulates macrophages through surface 
receptors TLR2 and dectin-1.  Mammals do not produce chitin, but chitinases and 
chitinase-like proteins have been found in human asthmatics and are thought to play 
important roles in the development of adaptive inflammation and fibrosis (1). 
Dust mites’ fecal pellets are another source of chitin and also contain proteolytic 
enzymes derived from the mite’s gut.  Dermatophagoides species synthesize cysteine and 
serine proteases that, when inhaled by mammals, directly cleave the tight junctions 
connecting airway epithelial cells.  This damage to the epithelium stimulates the release of 
alarmins, such as IL-33 and TSLP, and damage-associated molecular patterns (DAMPs), 
namely ATP and uric acid.  Alarmins can directly stimulate the secretion of Th2 cytokines, 
recruitment of eosinophils, and AHR.  ATP influences mucin production and recruitment 
of neutrophils.  Uric acid has been shown to be critical to the development of Th2-type 
allergic inflammation and AHR in mice, and both DAMPs upregulate the recruitment of 
eosinophils to the damaged airway (1).    
Mite allergens vary in size, with smaller particles able to penetrate more deeply into 
the lung.  Larger particles, those 4.7 µm and greater in diameter, are more common and 
more likely to be inhaled.  However, particles as small as 1.1 µm across may also be present 
in the indoor environment (40) and will be deposited further into the lung. 
Clinical evidence suggests that the age at which sensitization to HDM allergen 
occurs has a large impact on the severity of related inflammatory responses.  In a study 
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which compared the lung function of atopic and nonatopic children in Germany, 90% of 
the nonatopic children displayed normal lung function and no inflammatory symptoms.  
Atopic children, however, who had been sensitized to perennial allergens like HDM during 
their first three years of life, displayed poor lung function; their symptoms worsened when 
they were re-exposed to those allergens.  A British cohort study spanning the first eight 
years of life found that sensitization to HDM in particular increased the risk of 
inflammatory respiratory disease in 87% of enrolled individuals.  These studies suggest 
that children are particularly susceptible to the formation of future allergies during 
organogenesis and early physical development (40). 
 
1.2.2 Murine Sensitization to House Dust Mite Allergen 
Mice can be sensitized to ovalbumin (OVA), house dust mite allergens, cockroach 
allergens, Aspergillus fumigatus, or ragweed pollen; some of these approaches may require 
the addition of adjuvants such as alum or endotoxin.  All of these immunizations are 
capable of eliciting a Th2 response and allergen-specific IgE production.  Subsequent 
exposures to the same allergen following sensitization evokes in murine models all the 
classical signs of asthma in humans, i.e., AHR, eosinophilia, and goblet cell hyperplasia 
(2). 
The currently accepted murine model of asthma involves HDM allergens.  Some 
researchers focus on specific elements of HDM extract, such as Der p 2, a cysteine protease 
borne by Dermatophagoides species (41).  Experimental models utilizing this allergen 
often include a purified suspension of Der p 2, produced by expression of the protease by 
E. coli and subsequent affinity chromatography and dialysis (41).  The sensitization and 
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challenge protocol has in many cases been adapted from existing protocols for OVA 
sensitization.  These may include whole HDM extract and/or purified Der p 2 in 
combination with alum to ensure an allergenic response; and the sensitization exposure, 
whether intranasal or intraperitoneal, is always followed by subsequent challenge 
exposures a number of days thereafter (41, 42).   
While this method is effective in generating an inflammatory response in the mice, 
it is not an ideal model of asthma.  Real-world exposure to Dermatophagoides includes an 
array of allergenic and inflammatory components; utilization of any single substance in 
isolation will necessarily yield an inaccurate depiction of reality.  Neither does reliance on 
adjuvants, e.g., aluminum hydroxide, mirror in situ exposure.  Even the traditional model 
of OVA-induced asthma presents an incomplete picture of true allergic asthma: OVA is 
not naturally allergenic to humans and is thus limited in clinical relevance; and prolonged 
exposure of mice to OVA can induce immunological tolerance and reduced responsiveness 
of the airways (43).  Furthermore, the sensitization step of the OVA protocols typically 
uses dermal, subcutaneous, or peritoneal routes of exposure, rather than introducing the 
allergen directly to the respiratory tract (43).   
In contrast, the model originally devised by Hammad et al. utilizes a commercially-
prepared extract of whole dust mite (Greer Laboratories), which is injected directly into 
the trachea.  This elicits localized sensitization of the airways, rather than systemic 
sensitization, and no adjuvant is necessary to achieve the desired inflammatory response 
(44).  This presents a more realistic exposure method and a clinically-relevant—indeed 
ubiquitous—human allergen, with no additives present to obscure the effects of that 
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allergen (45).  We have since adapted this model to utilize oropharyngeal instillation rather 




2.0 The Interaction of Multi-Walled Carbon Nanotubes with Allergic Inflammation 
in the Lung 
2.1 An Introduction to Multi-Walled Carbon Nanotubes 
 Multi-walled carbon nanotubes (MWCNT) are a type of engineered nanoparticle 
(ENP).  ENP are defined as being smaller than 100 nm in any one dimension (46).  Carbon 
nanotubes (CNT) are a category of ENP constructed of carbon lattices.  These include 
single-walled carbon nanotubes (SWCNT)—which are simply a single layer of graphite 
rolled into a hollow tube—and MWCNT.  MWCNT, accordingly, are ENP composed of 
multiple graphitic sheets rolled and nested to form a series of concentric tubes—the 
outermost bounds of which are <100 nm in either diameter or length.  Many CNT are 
between 0.7 and 10 nm in diameter, and MWCNT typically display interlayer spaces of 
0.342-0.375 nm.  They may be as long as several mm (47). 
 
 
Fig. 2.1: Basic carbon nanotube morphology, including TEM images (a, c) and schematic 
drawings (b, d).  Images a and b depict the structure of a multi-walled carbon nanotube; c 
and d depict a bundle of single-walled carbon nanotubes. (Adapted from (47).) 
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Because of their highly stable chemical structure and high aspect ratios, MWCNT 
and similar engineered carbon nanomaterials possess extraordinary thermal conductivity 
and tensile strength (48).  These qualities make MWCNT useful in a wide range of 
applications, ranging from electronics to medical implants and drug delivery mechanisms 
(47, 49).  However, the same qualities that make MWCNT useful in industrial applications 
may also make them bioactive.  Exposure to MWCNT is of particular interest because of 
their small size and fibrous structure.  The dimensions of some such particles are very 
similar to those of other mineral fibers, such as asbestos, and animal studies have 
demonstrated correspondingly similar pulmonary effects, including pulmonary 
inflammation and rapidly-developing fibrosis (50). 54 animal studies were reviewed by 
NIOSH.  44 of these reported pulmonary inflammation; 27 observed granuloma formation; 
and 25 studies gave evidence of fibrosis following nanotube inhalation. 
Available data further reveals that carbon nanotubes elicit fibrosis in less time and 
at lower dosages than ultrafine carbon black or quartz dust (50). The myriad types of 
nanotubes vary in shape, size, chemical functionalization, and catalyst contamination; 
these differences make understanding their potential as health hazards a particularly 
complex problem (50). Characteristics of toxicological interest include length, diameter, 
aggregation, aspect ratio, rigidity, contamination, and release of ROS (50). Particle 
retention in the lung is a major concern, given the aspect ratio and rigidity of MWCNT 
(50).  Both SWCNT and MWCNT have been found in the lungs of mice months after 
pharyngeal aspiration (51). The relative degrees of human risk posed by the many varieties 
of CNT are critical topics of study.  
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Carbon nanotubes with high aspect ratios appear to be more dangerous than their 
shorter counterparts.  Of four types of nanotubes injected into the peritoneal cavities of 
mice, three retained their original lengths and elicited both inflammation and fibrosis.  The 
remaining sample, which was less durable and broke into shorter pieces, induced 
considerably less inflammation (52). 
The toxicity of multi-walled carbon nanotubes can also be affected by the degree 
of particle aggregation, which in turn is determined by the relative flexibility and aspect 
ratio of the nanotubes in question (53).  MWCNT have a strong tendency to aggregate into 
bundles, or assemblages.  Those assemblages group into clumps, which are mostly non-
respirable.  Thus, those larger agglomerates must be broken up before experimental 
inhalation and are less likely to pose a health threat in real-world exposures; smaller 
assemblages can be more easily respired.  Assemblages of all sizes may be 
electrochemically bonded, and attempts to disperse them can therefore cause nanotube 
breakage and subsequent formation of even larger agglomerates (48). 
 
2.2 Regarding the Nickel Content of MWCNT 
Nickel has been identified as the most prevalent contact allergen, and cause of 
contact hypersensitivity, in the industrialized world (45).   Approximately 15% of the 
global population suffers from contact sensitivity to metals; of these, allergy to nickel is 
the most common (54).   Though originally an occupational hazard of the metal-working 
industry, since WWII nickel sensitivity has become increasingly common in the general 
population, largely due to fashion and lifestyle trends (55).  An estimated 65 million 
Europeans have been sensitized to Ni2+ and experience allergic contact dermatitis in 
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response to jewelry, coins, and other belongings made with nickel-containing alloys (45).  
The precise molecular mechanisms of nickel sensitivity are still being investigated, but the 
evidence to date suggests a unique sensitization process.   
 
 
Fig. 2.2: Sensitization to nickel (II) ions.  Ions stimulate production of inflammatory 
cytokines by epithelial cells, triggering antigen presentation by APCs to naïve T cells.  
Subsequent re-exposure induces proliferation of antigen-specific T cells and migration to 
the site of exposure.  (Adapted from (54).)   
 
When nickel (II) ions are released from alloys present in, or in contact with, the 
body, these ions activate epithelial cells, which produce cytokines such as IL-Iβ and TNF-
α.  Those cytokines are recognized by antigen-presenting cells (APCs), including DCs, 
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which then migrate to the draining lymph nodes and present the ionic allergen to naïve 
CD4+ T cells.  Upon repeated exposure to the nickel allergen, activated antigen-specific T 
cells enter the bloodstream and stimulate the visible signs of hypersensitivity at the site of 
exposure (54).   
Unlike other allergens, which act only indirectly on Toll-like receptors, nickel 
triggers PRR signaling directly by activating NF-κB, IRF3, and p38/MAPK/MKK6 signal 
transduction cascades (56, 57).  This makes nickel the only contact allergen to directly 
trigger NF-κB-dependent activation of DCs.  It has been further demonstrated that TLR4 
is necessary to the development of nickel sensitivity in humans (56).  This mechanism is 
dependent on non-conserved histidine residues and can therefore not be implemented in 
mice without some engineering.  Most murine models of nickel allergy utilize adjuvants to 
elicit the desired inflammation, but it is also possible to accurately model nickel allergy by 
using a transgenic mouse transfected with the human TLR4 gene (56, 57).  It has also been 
observed that expression of the TSLP receptor is upregulated during nickel-induced 
inflammation, which suggests a role for TSLP involvement.  Inhibition of TSLP synthesis 
decreased the delayed-type hypersensitivity reactions in mice exhibiting nickel-induced 
allergy (57). 
The nickel content of ENP is thus of immunological concern.  A variety of 
techniques exist for the manufacture of ENP and MWCNT in particular; some of the 
methods most commonly used to generate industrial quantities of MWCNT rely on 
chemical-vapor deposition or the catalytic decomposition of hydrocarbons (47).  Such 
methods require the addition of transition metal catalysts to the forming nanomaterial.  
Though these strategies are aptly suited for large-scale production, the use of catalysts 
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typically results in decreased purity of the finished product, as metal residues contaminate 
the carbon lattice and diminish the overall stability (47). 
The existing body of evidence suggests that the nickel content is also of 
toxicological importance.  Shvedova et al. reported that the degree of metal content in CNT 
appeared to be a factor in determining the cytotoxicity of that sample.   Specifically, higher 
percentages of iron and nickel catalysts generated greater amounts of hydroxyl radicals and 
significantly decreased cellular viability in vitro and in vivo (58, 59).  Lam et al. observed 
that while all CNT containing a metal catalyst produced adverse lung effects, whether in 
small proportion or large, CNT contaminated with nickel in particular were more cytotoxic 
than others (60).  It has also been reported by our own colleagues that nickel-bearing 
MWCNT elicited significant lung pathology (61).  This study utilized IL-1β and IL-18 
release as metrics of NLRP3 inflammasome activity, and both of these cytokines were 
significantly upregulated in the lungs of mice dosed with nickel-contaminated MWCNT.  
Furthermore, increased release of these cytokines correlated with increased nickel content 
in the MWCNT used, while direct cytotoxicity did not correlate.  This suggests that while 
nickel content may not be a reliable predictor of ENP toxicity, it is intimately involved 
with the stimulation of inflammatory responses following introduction of ENP to the lung 
(61). In the following study, we examined the capacity of nickel-bearing MWCNT to 
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Multi-walled carbon nanotubes (MWCNT) are used in a broad range of 
applications, including medical treatments, construction in the aerospace industry, and 
electronics manufacture. As demand for nanomaterials expands, so does the urgency of 
establishing an appreciation of the degree of health risk associated with their production 
and use. Inhalation represents a likely route of exposure; consequently, in this study we 
investigated whether MWCNT influenced the development of allergic inflammation. 
MWCNTs introduced into the lungs of mice resulted in a rapid increase in the number of 
eosinophils present in the airways that was observable within 24h. The inflammatory 
response elicited was also associated with an increase in the level of cysteinyl leukotrienes 
(cys-LT) present in the BALF (bronchoalveolar lavage fluid). In contrast, the eosinophil 
response developed in the absence of detectable amounts of the Th2-associated cytokines 
IL-4, IL5, or IL-13. Cys-LT were implicated in the inflammatory response since inhibition 
of cys-LT biosynthesis using the 5-lipoxygenase inhibitor, Zileuton, resulted in marked 
reduction in the severity of inflammation observed. Moreover, MWCNT instilled into mice 
with pre-existing allergic lung inflammation, elicited by house dust mite (HDM), markedly 
exacerbated the level of airway inflammation, which was characterized by a pulmonary 
eosinophilia, lymphocyte infiltration and raised cys-LT levels. The intensity of the 
inflammatory response elicited by either MWCNT alone, or in conjunction HDM allergen, 
correlated with the level of nickel present in the material, since preparations that had higher 
levels of nickel (FA21: 5.54% Ni by weight) were highly effective at eliciting 
inflammatory responses while preparations containing lower amounts of nickel (FA04: 
2.54% Ni by weight) failed to initiate or exacerbate allergic inflammation. In summary, 
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MWCNT in the lung were found to promote eosinophilic inflammation and exacerbate 
existing allergic lung inflammation via the induction of cys-LT biosynthesis. These 
findings suggest that exposure to airborne MWCNT is likely have adverse health effects in 
individuals suffering from atopic asthma, and further investigation of the potential 




The commercial demand for nanoparticle-based materials has expanded rapidly in 
recent years. More than 190,000 metric tons of nanoparticle-based composites were 
produced in 2012, and that quantity is projected to exceed 500,000 metric tons by 2019. 
As the industry grows, the likelihood of workers and consumers being exposed to airborne 
nanoparticles increases. Thus, assessment of any health risks associated with these 
materials will become increasingly important. Of the many types of nanoparticles 
available, multi-walled carbon nanotubes (MWCNT) are among the most useful for 
industrial and medical applications. MWCNT possess excellent tensile strength and 
electrical conductivity and can be easily functionalized for medical use (62). However, the 
same properties that make MWCNT so useful also make them potentially hazardous. By 
design, MWCNT have high aspect ratios and, while only a few nanometers wide, may be 
several micrometers long (63). As in the case of asbestos fibers, MWCNT are able to 
aggregate within the lung interstitium and are not easily degraded by alveolar macrophages. 
Health effects similar to asbestosis have been reported, including pulmonary fibrosis and 
granuloma formation, in addition to lung inflammatory responses and cytotoxicity (64, 65). 
There have been significant advances in our understanding of MWCNT toxicity, yet the 
cellular and molecular events that underpin its inflammatory capacity remain unclear. In 
this study we examined the ability of MWCNT to elicit and exacerbate allergic lung 
inflammation and sought to determine the role of cys-LT in this process.  
 Allergic asthma is a complex and chronic inflammatory disease of the airways that 
affects more than 300 million people worldwide. In highly populated regions of the globe, 
which include both North and South America, almost 85% of asthmatics are allergic to 
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house dust mite (HDM) (66, 67). Asthma is characterized by airway hyperreactivity, 
contraction of the smooth muscle, goblet cell hyperplasia, increased mucus production and 
eosinophil recruitment. Many of these pathological elements are thought to be a 
consequence of the activation of Th2 cells and their associated cytokines, including IL-4, 
IL-5, IL-9, and IL-13. In this study, MWCNT entering the airways were shown not only to 
promote the onset of eosinophilic inflammation but also to exacerbate established allergic 
lung inflammation. The intensity of these effects was shown to be highly dependent on the 
level of nickel present in the material since MWCNT with low levels of nickel were poor 
at promoting inflammatory responses. The eosinophilic inflammation elicited following 
MWCNT exposure required the action of cys-LT since this process was inhibited by 
treating mice with a 5-LO inhibitor. 
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2.3.3 Materials and Methods: 
 
Mice  
C57BL/6 (The Jackson Laboratory, Bar Harbor, ME) (10-16 weeks old) were used 
throughout this study. Mice were bred under pathogen-free conditions in a barrier facility 
and experimental animals maintained in micro-isolator cages and treated in accordance 
with National Institutes of Health guidelines and the American Association of Laboratory 
Animal Care regulations. Animal experiments were approved by the University of 
Montana, Institutional Animal Care and Use Committee, IACUC according to National 
Institute of Health guidelines.  
 
Media  
Cells were cultured in RPMI 1640 supplemented with 10% fetal bovine serum 
(CM-RPMI), (Hyclone Fetal Calf Serum, Thermo Scientific), L-glutamine, penicillin & 
streptomycin, HEPES, Sodium Pyruvate (Gibco Life Technologies) and 2-
mercaptoethanol (Sigma-Aldrich, St. Louis, MO).   
 
Intratracheal Administration of Multi-Walled Carbon Nanotube Preparations  
The inflammatory response elicited by MWCNT entering the airways of naïve and 
HDM primed mice was examined. MWCNT containing 5.54% or 2.54% nickel (FA21 and 
FA04 respectively) were administered to adult wildtype C57BL/6 mice by oropharyngeal 
aspiration. The MWCNT used in this study were characterized by the Research Triangle 
Institute as part of the National Toxicology Program (NTP).  Nanoparticles used were 
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originally sourced by the NTP from SI, Inc. and MKI Corp., as described by Girtsman et 
al. (65), kindly donated by Dr. Andrij Holian (University of Montana, Table 1). 
 
Variety Nickel content  







FA21 5.54 27 5-15  429 
FA04 2.54 33 5-15 682 
  
                     Table 1: Physical characteristics of MWCNT used. 
 
To administer MWCNT (50 µg), 30 µL of MWCNT suspension (1.67 mg/mL) was instilled 
into C57BL/6 mice via oropharyngeal aspiration as previously described (65). Briefly, 
mice were anesthetized with inhaled isoflurane, then suspended from piano wire by the 
upper incisors and MWCNT suspension was pipetted into the trachea. The level of airway 
inflammation and fibrosis was examined after 24h and 6 days.  
 
Sensitization of Mice to House Dust Mite Allergen (HDM) Prior to Instillation with 
MWCNT 
To prime mice to HDM and promote allergic lung inflammation, mice were 
sensitized to HDM on day 0 by the intranasal administration of 100 µg of HDM allergen 
(Dermatophagoides pteronyssinus, Greer Laboratories) in 30 µl of PBS and then on days 
7 and 14 by intranasal treatment with 50 µg of HDM (30µl total volume). HDM allergen 
preparations used throughout this study contained minimal levels of LPS. Control groups 
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comprised mice receiving 30 µl of PBS on days 0, 7 and 14. To determine the level of 
mucosal inflammation, BALF and lung tissue were harvested on day 16, 48h after the last 
challenge. To examine the proinflammatory properties of MWCNT, mice were 
additionally challenged with a single 50 µg dose of MWCNT (30 µl of a 1.67 µg/mL 
suspension) administered oropharyngeally 24h prior to harvest (Figure 2.3). 
 
Determining the Level of Pulmonary Inflammation  
Mice were euthanized 24 hours post-MWCNT instillation. Lung lavage was 
performed and whole lung tissues were harvested.  BALF was divided for analysis of cell 
populations via flow cytometry, cysteinyl leukotriene (cys-LT) and cytokine production 
via EIA and sandwich ELISA, and eosinophil peroxidase (EPO) by colorimetric assay.  
Lung tissues were reserved for histological examination using H&E and trichrome stains. 
Bronchoalveolar lavage was performed to collect bronchoalveolar lavage fluid (BALF) for 
analysis. Eosinophil peroxidase (EPO) levels in the lavage cells were determined by 
colorimetric analysis using orthophenylene diamine dihydrochloride as detailed previously 
(68). Cell differential percentages were determined by light microscopic evaluation of 
Hema3-stained cytospin preparations and expressed as absolute cell numbers. Lung tissue 
was dispersed by collagenase (Type IV; Sigma-Aldrich), and lung mononuclear cells 
(LMC) were isolated by Percoll (Sigma-Aldrich) density gradient for functional analysis. 
 
Measurement of Cytokines 
BALF chemokine or cytokine levels were determined using ELISA for 
measurement of IL-4, IL-5 (Duoset, R&D Systems) and IL-13 (Quantikine, R&D 
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Systems), or using the sensitive Mouse V-Plex Pro-Inflammatory Panel 1 assay and Meso 
Quickplex 120 reader (MesoScale Discovery, MD) for measurement of other cytokines 
(IL-4, IL-5, TNF-α, IFN-γ and IL-12p70).  
 
Histological Determination of Peribronchial Inflammation and Collagen Deposition 
Lung tissue was fixed in 4% paraformaldehyde and embedded in paraffin using a 
Leica ASP 300 tissue processor (Leica, Bannockburn, IL). Microtome sections were cut at 
5µm thickness and stained with hematoxylin and eosin (H&E) using a Shandon Varistain 
24-4 (Thermo Fisher Scientific). In addition, sections were stained using Gomori’s 
Trichrome (EMD Chemicals, Gibbstown, NJ) for histological analysis using a Thermo 
Shandon automated stainer. The level of peribronchial inflammation (H&E stained) or 
collagen deposition (Trichrome stain) was analyzed by microscopy, and the transmitted 
light images were collected on a Nikon Eclipse 800 microscope equipped with an Olympus 
DP 26 camera and cellSens software (Version 1.9).  
 
Measurement of Cysteinyl Leukotrienes 
Prior to assay, the IgG present in the BALF (500 µl) was depleted by incubating 
with 50 µl of packed protein G-Sepharose beads (GE Healthcare). After centrifugation 
BALF was assayed for the presence of cysteinyl leukotrienes (Express ELISA, Cayman 




Cells (LMC, BALF, or splenic cells) were FcgR blocked using 2.4G2 antibody 
(ATCC) and stained with combinations of the following mouse conjugated mAb (all 
purchased from BioLegend): allophycocyanin (APC) or FITC anti-CD3, APC/Cy7 anti-
CD4, PE anti-CD8a, APC or PE anti-CD11c, PE or APC/Cy7 anti-I-A/I-E, APC/Cy7 anti-
Ly6G, APC or APC/Cy7 anti-Ly6C, APC/Cy7 anti-Ly-6G/Ly6C (Gr-1), PE, FITC or 
Brilliant Violet 421 anti-CD11b, APC or PE anti-F4/80. In addition, PE anti-Siglec-F (BD 
Biosciences) was used to stain eosinophils. Flow cytometric acquisition was performed on 
a FACSAria II (BD Biosciences) by 4-color analysis using FACSDiVa software and 
FlowJo, with a minimum of 50,000 live, single-cell events per sample collected.  
 
Treatment of Mice with Zileuton to Inhibit MWCNT-Induced Inflammation  
C57BL/6 mice were treated by the oropharyngeal administration of either Zileuton 
10 mg/Kg (Tocris Biosciences) or vehicle (0.5% methyl-cellulose/0.2% Tween 80 in 
water) 3h before administration of 50 µg of FA21. Controls comprised mice treated with 
carrier alone. The level of inflammation elicited was evaluated by harvesting BALF and 
monitoring eosinophils and cys-LT levels.  
 
Statistical Analysis 
Data were analyzed using GraphPad Prism 5.0 (GraphPad, La Jolla, CA). Results 
involving two variables were analyzed by two-way ANOVA with a Bonferroni post-hoc 
test. Data comparing two groups were analyzed using an unpaired t test. Figures show 
combined data from multiple studies or independent repeats (two or more). Data shown are 
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mean ± SEM. A p value < 0.05 was considered statistically significant. Significance 






Characterization of the Inflammatory Response Elicited Following MWCNT Inhalation  
The two different types of MWCNT compared in this study were FA21 (Sun Nano) 
and FA04 (MK Impex Canada), both of which have been characterized (61) and shown to 
possess several similar physical characteristics which include similar specified length (5-
15 pm) and diameter (27-33 nm). To discern their potential inflammatory properties, 
particles were instilled directly into the airways of mice and evidence of an inflammatory 
response was sought. A single instillation of 50 µg of FA21 MWCNT into the airways 
elicited the rapid development of inflammation after 24 hours (Fig. 2.4). The BALF 
recovered from C57BL/6 mice receiving FA21 instillations contained significantly raised 
numbers of eosinophils that were detected by increased levels of cell-associated EPO (Fig. 
2.4A) and confirmed by cell differential staining of BALF cells (Fig. 2.4B). Both BALF 
EPO activity and eosinophil counts remained significantly raised for 6 days after a single 
instillation of FA21 (p<0.05). Increased numbers of neutrophils and macrophages were 
also observed in the BALF following MWCNT exposure; however, this did not reach 
significance and no evidence of lymphocyte infiltration was observed. To quantify cellular 
populations present in the airways after MWCNT exposure, inflammatory cells present in 
the BALF were also analyzed by flow cytometry (FACS Aria II, BD Biosciences) as 
previously described (69) (Fig. 2.4C). Eosinophils were identified through a gating strategy 
in which leukocytes were first selected by FSC and SSC, and CD11b+/F4/80- cells were 
further characterized by degree of Siglec-F and GR-1 expression. Eosinophils were 
identified by high expression of Siglec-F and neutrophils by GR-1 expression. Alveolar 
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macrophages were excluded on the basis of F4/80 staining. This process revealed that 
6.43% of the cells recovered from the BALF 24 hours after exposure to FA21 were 
eosinophils, compared to 0% in the lungs of unexposed mice. While FA21 instillation 
resulted in the recruitment of only low numbers of CD11b+F4/80-Siglec-F-GR1+ 
neutrophils in the BALF (Fig. 2.4C), MWCNT instillation did result in a large increase in 
the number of neutrophils present in the lung tissues (i.e., following dispersion of the tissue 
with collagenase). Histological analysis of lung tissue using H&E and trichrome staining 
revealed that FA21-exposed mice developed a pronounced peribronchial and perivascular 
inflammation compared to control animals (Fig. 2.4D).  Trichrome staining of the same 
lungs reveals negligible deposition of collagen, indicating that fibrogenesis had not yet 
begun within six days of MWCNT instillation. 
 
A Role for Cysteinyl Leukotrienes in Promoting MWCNT-Induced Inflammation 
Although FA21 promoted the rapid onset of an eosinophil recruitment to the 
airways, Th2 cytokines were universally absent from the BALF of FA21-exposed mice, as 
evidenced by FA21 exposure not resulting in a significant increase of IL-13 levels in the 
BALF (Fig. 2.5). The chemokine CX3CL1 plays an important role in the recruitment of 
monocytes and NK cells to the tissues and plays an important role in homeostatic and 
inflammatory states (70). While CX3CL1 was constitutively present in the BALF of naïve 
C57BL/6 mice, FA21 instillation resulted in a significant reduction in its levels evident 
both 1 and 6 days after exposure. IL-22 has previously been shown to inhibit eosinophilic 
inflammation during allergic inflammation (71, 72). Given that eosinophils were the 
principal inflammatory cell present in airways of FA21-exposed mice, the presence of 
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eosinophil chemotactic and survival factors was sought. It has been previously reported 
that cys-LT can promote eosinophil migration (73) and leukotrienes play an essential role 
during allergic lung inflammation (74). Interestingly, only low levels of cys-LT were 
present in the BALF of mice that were instilled with vehicle. In contrast, the oropharyngeal 
administration of FA21 resulted in the marked increase in the level of cys-LT present 24 h 
later in the BALF, increasing from 184 pg/mL in vehicle challenged to 751 pg/mL in 
response to MWCNT exposure (Fig. 2.5). Since eosinophils can themselves produce cys-
LT (75), it was important to resolve whether their raised levels in the BALF were simply 
the result of increased numbers of eosinophils or whether already-present cys-LT were the 
cause of eosinophil migration into the airway. To examine the latter possibility, the effect 
of blocking leukotriene biosynthesis was ascertained by treating mice with an inhibitor of 
5-lipoxygenase. To this end, mice instilled with FA21 were treated with the 5-lipoxygenase 
inhibitor, Zileuton (Tocris Biosciences), and the effect on MWCNT-induced inflammation 
was investigated. Mice were pre-treated with Zileuton (10 mg/Kg) 3h before the 
oropharyngeal administration of 50 µg of FA21 of vehicle. Twenty-four hours later the 
level of pulmonary inflammation and level of cys-LT present in BALF were determined. 
Interestingly, pretreatment of mice with Zileuton reduced the cys-LT levels present in the 
BALF by 62% (p<0.01) (Fig. 2.6A) in mice exposed to MWCNT. The reduction in the 
level of cys-LT was coincident with a corresponding decrease in the degree of observed 
eosinophilia (Fig. 2.6B). 
 
The Exacerbation of HDM-Induced Allergic Lung Inflammation by MWCNT  
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At the time points examined, the level of eosinophilic inflammation elicited by 
FA21 alone was markedly less severe than that typically elicited by known allergens like 
house dust mite. This is likely a consequence of the low numbers of circulating eosinophils 
present in a non-allergic animal. To assess the potential of MWCNT to exacerbate airway 
inflammation in allergen-sensitized animals, we added a single instillation of FA21 to the 
final day of our murine model of allergic asthma (Fig. 2.6). As the house dust mite is a 
globally ubiquitous allergen to which as many as 85% of asthmatics react (1), this model 
uses a series of three doses of HDM over two weeks to sensitize mice and prompt an 
allergic response. Observed inflammatory responses correlate with the findings of our 
previous studies (69), with mice sensitized to HDM displaying significantly elevated 
eosinophilia and cys-LT production compared to sham-treated mice (Fig. 2.7). 
Interestingly, mice that were sensitized to allergen and further dosed with FA21 showed a 
marked increase in inflammation compared to mice given only allergen or only FA21. 
Differential cell counts reveal a clear influx of eosinophils into the airways, most notably 
in mice exposed to both allergen and MWCNT. Alveolar macrophages and lymphocytes 
were also present, in much lower numbers (Fig. 2.7A). Specifically, exposure of either 
naïve mice, or mice treated with HDM allergen, to FA21 did not result in increases in the 
number of BALF CD4+ or CD8+ T cells (Supplemental Fig 2.11). As before, EPO 
measurements confirmed the presence of a considerable eosinophil population in mice 
instilled with MWCNT (Fig. 2.7B). BALF was further analyzed by flow cytometry; this 
revealed a striking ten-fold increase in the airway eosinophil population of dual-exposed 
mice over those exposed only to MWCNT (Fig. 2.7C). This inflammatory response can be 
visualized quite clearly in histological images of lung tissue harvested from such mice just 
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24 hours after MWCNT instillation (Fig. 2.7D). Dual-exposure also elicited significantly 
greater degrees of cys-LT biosynthesis than did either single exposure (Fig. 2.7E). This 
confirms that MWCNT introduced to the lungs is indeed capable of exacerbating allergic 
inflammation already in progress.  
 
Correlation between the Degree of Inflammation Elicited and the MWCNT Nickel Content  
To determine whether differences in physical properties could be correlated with 
the relative pro-inflammatory properties of FA21 and F04, each of these materials was 
administered and the inflammatory processes compared. Previous analysis of the physical 
properties of FA21 and FA04 materials revealed that both form agglomerates 
(agglomeration sizes being 712 nm and 675 nm, respectively) with the major contaminant 
in both being nickel (comprising 5.54% and 2.54% respectively). As detailed previously 
(61), instillation of 50 µg of FA21 into the lungs of naïve C57BL/6 mice elicited a strong 
eosinophilic response evident 24 hours later. However, in marked contrast to FA21, the 
oropharyngeal instillation of an equivalent amount of FA04 did not result in a pulmonary 
eosinophilic response that was significantly different from mice treated with vehicle or the 
untreated controls, as measured by cell-associated BALF EPO activity (Fig. 2.8A). 
Importantly, mice exposed to FA21 displayed noticeably higher levels of cys-LT level in 
the BALF (720 ng/mL) compared to mice given FA04 (Fig. 2.8B). Consistent with the 
eosinophilic response elicited, FA04 instillation failed to raise BALF cys-LT levels 
significantly above what was found in the vehicle-treated control group (Fig. 2.8B). To 
further investigate the biological properties of these two materials, their pro-inflammatory 
properties were compared in mice which had been sensitized and challenged with HDM 
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allergen. Pulmonary eosinophilia elicited by HDM allergen was over three-fold higher than 
that caused by FA21 administration alone (Fig. 2.9). In HDM-challenged animals the 
instillation of FA21 24 hours prior to harvesting BALF resulted in a two-fold exacerbation 
of the level of pulmonary eosinophils present as determined by cell differential counts and 
cell-associated EPO activity (Fig. 2.9). In marked contrast, FA04 exposure 24 hours prior 
to harvest resulted in no significant difference in the level of eosinophilia over that elicited 
by the HDM allergen alone (Fig. 2.9). The marked differences in observed inflammatory 
responses elicited correlates with the level of nickel contamination of the two materials 
(5.54% by weight of FA21 is residual nickel catalyst compared to 2.54% of the mass of 
FA04). These observations suggest a biologically active role for this contaminant and likely 





As a consequence of the growth of the nanotechnology industry, there has been a 
striking increase in the types and quantity of MWCNT currently in production. This trend 
raises the likelihood of human exposure to these particles and necessitates a better 
appreciation for their potential impact on human health. The health risks arising from the 
respiration of MWCNT particles are of concern since this material is fibrous and bears 
several characteristics displayed by asbestos. MWCNT entering the airways of mice have 
been shown to elicit several proinflammatory events that originate from the activation of 
the NLRP3 inflammasome (61) and the induction of IL-6, TNF-a and IL-1b (48) and are 
associated with the formation of granulomas and development of airway fibrosis (63, 76, 
77). MWCNT exposure also causes epithelial damage (48, 61, 78) by a process involving 
COX-2 (79) and is associated with epigenetic regulatory events arising from changes in 
global methylation patterns (80).  
Our study evaluated the inflammatory and fibrotic responses elicited by inhaled 
MWCNT particles and investigated whether such exposures exacerbated pre-existing 
allergic lung inflammation. Strikingly, the entry of MWCNT into the airways of naïve mice 
elicited the rapid recruitment of CD11b+F4/80-GR-1- eosinophils into this compartment 
and CD11b+F4/80-GR-1+ neutrophil recruitment to the lung. Instillation of MWCNT was 
associated with the development of a mild peribronchial and perivascular inflammation 
and collagen deposition in the lungs of MWCNT-exposed animals, which could be detected 
by trichrome staining six days after exposure. 
While the inflammatory response induced by MWCNT alone was present for 
several days, this response was only 10% of that observed following inhalation of a known 
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allergen, HDM. Triggers for eosinophilic inflammation can either be non-allergic or 
allergic in nature with the former involving ILC2 activation and the latter pathway being 
dependent on T cells (81). The inflammatory response elicited by FA21 MWCNT revealed 
no detectable IL-5, IL-13, IL-22, CX3CL1 or IL-33; however, there was a marked increase 
in the level of cys-LT in the BALF within 24h of a single instillation of MWCNT. Mast 
cells, eosinophils, basophils, dendritic cells and macrophages are known to be cellular 
sources of cys-LT.  
Leukotrienes are mediators derived from arachidonic acid by the action of 5-
lipoxygenase (5-LO) resulting in the generation of LTA4 (73). LTC4 is generated by the 
conjugation of glutathione to LTA4; the extracellular derivatives of this mediator are 
subsequently formed by enzymes that generate LTD4, which mediates airway constriction, 
and ultimately the stable metabolite LTE4 (82). Cys-LT play an important role in the 
development of allergen-induced airway inflammation and airway hyperresponsiveness 
(AHR) (83). The induction of cys-LT biosynthesis following inhalation of MWCNT played 
a central role in the inflammatory process since inhibition of leukotriene production, using 
a 5-LO inhibitor, Zileuton, markedly suppressed the level of pulmonary eosinophilia. Both 
leukotriene B4 and cys-LT are important lipid mediators that facilitate eosinophil 
recruitment in both man and mouse (73, 84). Two receptors for cys-LT have been 
described, CysLT1 and CysLT2. Cys-LT action via CysLT1 induces bronchoconstriction, 
tissue swelling, and increased mucus secretion, while activation of CysLT2 mediates 
inflammation, vascular permeability, and fibrosis (37). Cys-LT upregulate the expression 
of adhesion molecules by eosinophils (85, 86), leukocyte rolling (87) and chemokine 
expression (88).  
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Whether eosinophils present in the airways derive from cells resident in the lung 
tissue or are recruited from the blood remains unclear. The presence of resident, steady-
state eosinophils in normal non-inflamed intestinal and lung mucosa has been described 
previously (89). A population of lung-resident SiglecintCD62L+ eosinophils containing a 
ring-shaped nucleus have been described as being IL-5 independent	(90). This raises the 
possibility that cys-LT play a central role in promoting the migration of steady-state 
eosinophils into the airways. An additional proinflammatory property of cys-LT is that it 
synergizes with IL-33 to activate murine type 2 innate lymphoid cells, ILC2s (30, 91). 
ILC2s secrete IL-5 constitutively and express IL-13 on activation, consequently playing 
important roles in promoting eosinophil recruitment to the airways and promoting their 
survival (92, 93) and homeostasis (89). IL-33 has also been linked to the release of IL-13 
and subsequent increase in AHR and eosinophilia within 24 hours of MWCNT exposure 
(94).  
Several therapeutic agents, such as Montelukast (Singulair, Merck & Co., Inc.), 
specifically target CysLT1 while Zileuton (Zyflo) was the first USFDA approved 
competitive inhibitor of 5-lipoxygenase used for the treatment of atopic asthma (95). 
Leukotriene (LT) modifiers are anti-inflammatory drugs that are used in combination 
therapies with first-line asthma-controller medications. This suggests that a proven safe 
and effective drug can reverse some of the damaging effects arising from human exposure 
to MWCNT. Since blockade of 5-LO action results in inhibition of eosinophils, it appears 
that 5-LO and cys-LT could play critical roles in the development of airway inflammation.  
 Although FA21 MWCNT were effective at promoting eosinophilic inflammation 
in naïve mice, it was important to compare the magnitude of this response to that elicited 
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by a known allergen. HDM is a clinically relevant allergen which elicits pulmonary 
inflammation following inhalation without the need to resort to the use of immunological 
adjuvants (96). Repeated inhalation of HDM allergen results in the activation of both innate 
and adaptive immunity characterized by a pronounced CD4+ Th2 response, generation of 
specific IgE and infiltration of eosinophils into the airway (97), processes that typify the 
disease process in atopic asthma. In addition, it was important to resolve whether this 
material exacerbated previously established allergic lung inflammation. This was 
particularly relevant given the evidence that MWCNT appeared to promote eosinophil 
recruitment, a response that would be expected to be elevated if the number of circulating 
eosinophils was raised as during allergic inflammation.   
Both ILC2s (93, 98-100) and CD4+ T cells (24, 101) contribute to the inflammatory 
responses elicited by HDM; however, it is unclear which response was most influenced by 
the MWCNT. Instillation of FA21 resulted in a two-fold increase in the number of 
eosinophils entering the airway and a dramatic increase in the intensity of peribronchial 
and perivascular inflammation. As previously detailed, the exposure of mice to HDM 
resulted in raised levels of cys-LT present in the BALF; however, the levels of this mediator 
were doubled by instilling MWCNT into the airways 24h prior to analysis. The observed 
exacerbation of the inflammatory response suggests that exposure to these materials may 
have profound health consequences in individuals suffering from atopic asthma. This effect 
likely stems from the innate ability of MWCNT to elicit cys-LT release and the subsequent 
contribution of these mediators to airway inflammation (Supplemental Fig. 2.11). The 
effectiveness of MWCNT in exacerbating existing allergic inflammation may prove more 
problematic than their ability to initiate eosinophilic inflammation. Since FA21 
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administration did not result in the augmentation of Th2 cytokines in the BALF, it is most 
likely that cys-LT directly promote the recruitment of eosinophils.  
 
Dramatically lower eosinophilic responses were elicited following the instillation 
of FA04 compared to mice given FA21. The former preparation is known to contain 
significantly less nickel, implying that the difference in the inflammatory capacity of these 
two MWCNT may be a consequence of their nickel content. In the course of these studies, 
MWCNT containing low levels of nickel did not promote pulmonary eosinophilia when 
administered alone nor when administered to mice that had been previously sensitized to 
HDM allergen. The observation that nickel was essential for eliciting an eosinophilic 
response in the airway is intriguing and suggests that either the nickel content itself, or 
changes in physiochemical properties of the particles arising from nickel contamination, 
had profound effects on several physical attributes of the particles, such as their respective 
agglomerate sizes (Table 1). Moreover, instillation of FA21, but not FA04, was associated 
with the release of cys-LT, implying that the presence of nickel may facilitate the release 
of cys-LT.  
Nickel associated with MWCNT has been shown to promote inflammasome 
activation (61) in murine alveolar macrophages. Critically, activation of the inflammasome 
promotes leukotriene biosynthesis (102). Nevertheless, it is important to note that the 
nickel levels in the FA04 preparation were reduced rather than the metal being absent (i.e., 
FA04 and FA21 preparations contained 2.54% and 5.54% respectively). Consequently, any 
disparity in inflammatory effects mediated by nickel is likely to derive from differences in 
the amount of biologically active or released nickel. Critically, nickel has well 
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characterized proinflammatory properties. Nickel is a frequent cause of contact 
sensitization in humans and elicitation of type IV delayed-type hypersensitivity (DTH), in 
part by activating the Toll-like receptor 4 (45). In contrast, nickel sensitization of mice does 
involve TLR4 although activation of innate immunity is evident in C57BL/6 mice (103) 
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Figure 2.3  
Protocol to examine whether MWCNT exposure exacerbates the allergic 
inflammation elicited by HDM.  
To elicit allergic lung inflammation C57BL/6 mice were given a sensitization dose of HDM 
(100 µg) on day 0, and followed by two 50 µg challenge doses on days 7 and 14. To 
examine the proinflammatory properties of MWCNT, mice were additionally challenged 
with a single 50 µg dose of MWCNT (30 µL of a 1.67 µg/mL suspension) administered 
oropharyngeally 24h prior to harvest (day 16). Control/sham-treated mice were given PBS 
in place of HDM and MWCNT. The inflammatory response elicited was examined on day 




Figure 2.4  
Intratracheal administration of MWCNT (FA21) elicited pulmonary eosinophilic 
inflammation.  
To examine the inflammatory properties of MWCNTs, 50µg of FA21 was administered to 
C57BL/6 mice by oropharyngeal instillation (30 µL). Controls comprised mice treated with 
dispersion medium alone (vehicle). To examine the resultant inflammatory response, 
BALF and lung tissue were collected both one and six days after administration and the 
cellular composition examined. (A) EPO activity expressed by BALF cells was determined 
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after one or six days by colorimetric assay. EPO levels were notably elevated in mice dosed 
with FA21 alone compared to sham-treated mice after one day and remained significantly 
raised over six days (*p < 0.05 and ***p < 0.001 respectively). (B) Differential cell counts 
one day following MWCNT challenge, measuring the number of lymphocytes (LYM), 
eosinophils (EOS), neutrophils (NEU) and macrophages (MAC) present in BALF and 
expressed as the absolute cell number, revealed increased eosinophil recruitment to the 
airways. (C) The immune cells present in BALF from vehicle and FA21 exposed animals 
(one day) were examined by flow cytometry. Eosinophils were identified as 
CD11b+F4/80-GR1- cells expressing Siglec-F and neutrophils as CD11b+F4/80-GR1+ 
cells. In both cases, preliminary gating on FSC and SSC was performed, as described in 
the Methods. (D) Lung sections (5 µm) were stained using either H&E or Mallory 
trichrome revealing cellular infiltration and minimal collagen deposition, six days after 
MWCNT exposure. Groups comprised 4 mice (n = 4) and results are mean ± SEM *p < 




Figure 2.5   
The intratracheal administration of MWCNT resulted in the biosynthesis of cysteinyl 
leukotrienes in the absence of Th2-associated cytokines.  
C57BL/6 mice were challenged by the oropharyngeal instillation of 50µg of FA21 
MWCNT or dispersion medium (vehicle alone). BALF from both groups of mice was 
prepared after 24h and the levels of IL-22, IL13, CX3CL1 and cys-LT determined by 
ELISA. Cys-LT levels were raised 7-fold after 24h MWCNT exposure, IL-13 and IL-22 
levels remained unchanged, while the level of CX3CL1 was significantly decreased. 
Groups comprised  4 mice (n = 4) and results are mean ± SEM, *p < 0.05 and ***p < 0.001. 




Figure 2.6  
Inhibition of cys-LT biosynthesis using a 5-lipoxygenase antagonist also inhibited 
MWCNT-induced airway inflammation. To examine whether cys-LT contributed to the 
inflammation, C57BL/6 mice were treated by the oropharyngeal administration of either 
Zileuton 10 mg/Kg (Tocris Biosciences) or vehicle (0.5% methyl-cellulose/0.2% Tween 
80 in water) 3h before administration of 50 µg of FA21. Controls comprised mice treated 
with carrier alone. The level of inflammation elicited was evaluated by harvesting BALF 
and monitoring (A) eosinophils by measuring EPO activity by colorimetric assay and (B) 
cys-LT levels. Groups comprised 4 mice (n = 4) and results are mean ± SEM, *p < 0.05 





Figure 2.7  
Exposure to FA21 exacerbates HDM-induced allergic lung inflammation and 
promotes cys-LT production.  
The possibility that MWCNT exacerbated allergic inflammation was evaluated in HDM 
sensitized mice. Allergic lung inflammation to HDM was elicited in C57BL/6 mice by 
instillation of HDM allergen into the airway (Figure 1). Mice were challenged by MWCNT 
administered by oropharyngeal instillation of 50 µg of the material on day 15 and the level 
of inflammatory response elicited was determined on day 16 by examination of lung tissues 
and BALF.  Groups comprised mice treated with either FA21 only, HDM only, or both 
HDM and FA21. Control/sham-treated mice were given PBS in place of HDM and 
MWCNT. (A) Differential cell counts, measuring the number of lymphocytes (LYM), 
eosinophils (EOS), neutrophils (NEU) and macrophages (MAC) present in BALF and 
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expressed as the absolute cell number, revealed increased eosinophil recruitment to the 
airways. (B) EPO activity expressed by BALF cells was determined 24h after MWCNT 
challenge by colorimetric assay. EPO assays confirm significantly increased eosinophilia 
in mice exposed to both HDM allergen and FA21 compared to mice given allergen or HDM 
or FA21 alone. (C) Flow cytometry was performed on BALF cells enumerating 
CD11b+F4/80-Siglef-F+ cells lacking GR1. (D) Lung sections (5 µm) were stained for 
H&E to examine the cellular infiltration. In addition, BALF cells were cytospun onto glass 
slides and stained using Hema3 prior to microscopic examination, which revealed alveolar 
macrophages (AM), eosinophils (EOS), and MWCNT agglomerates.  (E) Cys-LT levels 
present in BALF were determined by ELISA. Groups comprised 4 mice (n = 4) and results 






Figure 2.8  
The severity of airway eosinophilic inflammation elicited by inhalation of MWCNT 
correlates with their nickel content.  
The effect of nickel on the inflammatory process was investigated by comparing the airway 
inflammation elicited by MWCNT with high (FA21) and low (FA04) nickel content. Fifty 
µg of FA21 or FA04 MWCNT was instilled into the airways of C57BL/6 mice and BALF 
collected 24 hours later.  (A) The level of eosinophil infiltration was determined by 
measuring BALF cell-associated (EPO) using colorimetric analysis. (B) The level of cys-
LT present in BALF was determined by ELISA. Results are mean ± SEM (n = 3), *p < 




Figure 2.9  
The effectiveness of inhaled MWCNT to exacerbate allergic lung inflammation 
correlates with their nickel content.  
C57BL/6 mice were treated with HDM allergen by oropharyngeal administration of 100 
µg HDM allergen on day 0, and 50 µg on days 7 and 14. Controls comprised mice treated 
with PBS. Both control and HDM sensitized mice were treated with either FA21, FA04 or 
vehicle and the level of inflammation determined by quantifying the cellular composition 
of BALF. (A) Cell differential counts in the BALF were determined and expressed as 
absolute numbers (per mouse) of lymphocytes (LYM), eosinophils (EOS), neutrophils 
(NEU) and macrophages (MAC). Data are representative of 3-4 independent experiments. 
(B) The level of eosinophil infiltration was determined by measuring BALF cell-associated 
EPO using colorimetric analysis. Results are mean ± SEM (n = 3), *p < 0.05 and ***p < 





Supplemental Figure 2.10 
Flow cytometry reveals no clear connection between CD4+ and CD8+ T lymphocytes 
and FA21 exposure.  
Sensitization of C57BL/6 mice to HDM resulted in increased populations of CD4+ and 
CD8+ T cells compared to sham-treated mice; however, addition of FA21 did not reliably 
elicit either increased or decreased T cell populations.  
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Supplemental Figure 2.11 
Proposed mechanism of inflammation elicited following FA21 exposure.  
Introduction of FA21 to the lung activates airway epithelia or alveolar macrophages to 
synthesize cys-LT. Active epithelial cells also stimulate differentiation of Th2 and/or ILC2. 







3.0 The Interaction of Pre- and Postnatal Wood Smoke Exposure with Allergic 
Inflammation in the Lung 
3.1 An Introduction to Wood Smoke 
3.1.1 Prevalence of Airborne Fine Particulate Matter 
 Air pollution in the form of fine and ultrafine aerosolized particles is one of the ten 
leading causes of poor health and premature death, with global mortality attributable to 
PM2.5 inhalation having reached 3.15 million deaths per year by 2010 (104). PM2.5 is 
defined as any airborne particle having an aerodynamic diameter of 2.5 micrometers or less 
(104, 105). The World Health Organization has stipulated that annual mean concentrations 
of inhaled PM2.5 should be kept below 10 µg/m3 and the daily mean below 25 µg/m3. 
However, large populations in the Middle East and Asia are exposed to levels of fine 
particulate far exceeding these guidelines (104). It is further estimated that 30% of the 
American population is routinely exposed to levels of PM2.5 in the ambient air which 
exceed those outlined as tolerable by the National Ambient Air Quality Standards 
(NAAQS) (106). Common sources of PM2.5 include urban smog produced by vehicles and 
industry; environmental dust, as in deserts; and organic combustion products, produced by 






Figure 3.1: Fine-fraction 
particulate matter (PM2.5) is 
many times smaller than 
visible particles, such as 





3.1.2 Known Adverse Effects of PM2.5  
 Particulate matter, particularly PM2.5, is widely considered hazardous to human 
health. Particle pathogenicity is determined by size, chemical composition, origin, 
solubility, and ability to generate reactive oxygen species (105). Smaller particles are 
deposited deeper within the lung upon inhalation than larger particles, which makes PM2.5 
notably more dangerous than particulate of greater diameter (105). Exposure to airborne 
PM2.5 has been associated epidemiologically with increased mortality rates, particularly 
among the elderly, caused by exacerbated asthma, chronic bronchitis, respiratory 
inflammation and infection, and lung carcinogenesis (105, 109-111). There is also 
epidemiological and laboratory evidence that such exposure elicits systemic inflammation, 
and long-term inhalation of PM2.5 can be correlated to increased risk of heart disease, 
cardiac event, insulin resistance, and diabetes (112-114).  
 A number of potential mechanisms for these adverse effects have been proposed. 
In vitro studies have determined that exposure to PM2.5 stimulates release of pro-
	 63	
inflammatory cytokines such as GM-CSF and IL-8 by bronchial epithelial cells; and 
prolonged exposure produces visible lung damage, e.g., thickening of bronchioli walls. 
(110). Additionally, it is thought that one of the major mechanisms of PM carcinogenicity 
is the induction of oxidative stress, in which exposure to combustion particles triggers the 
release of reactive oxygen species from alveolar macrophages (115, 116). This arises from 
the chemical composition of the particles in question: the carbon core of any given 
combustion particle has a variety of metals and hydrocarbons adhered to it (115, 117). 
Adhered metals would be sources of ROS, while PAHs would be decomposed into oxygen 
compounds capable of binding directly to DNA and forming adducts (115). In vivo study 
of urban residents has shown a small but significant increase in oxidative DNA damage 
associated with exposure to PM2.5 containing transition metals, using the biomarker 7-
hydro-8-oxo-2’-deoxyguanosine (8-oxodG) as a metric (118). 
 
3.1.3 Significance of Human Exposure to Wood Smoke 
The ubiquitous nature of fine particulate air pollution makes this an environmental 
exposure of global concern. Of particular local concern is the particulate derived from 
wood smoke, originating both indoors and outdoors. Wildfires and prescribed burns are 
significant sources of airborne particles, as well as gaseous pollution, that can temporarily 
increase the overall levels of air pollution over hundreds or thousands of square miles (107, 
119). Furthermore, relatively little is known about the health impacts of such planned and 
unplanned fires on exposed communities (119, 120). There is also a pressing need to 
examine the adverse health effects of indoor wood smoke. Wood-burning stoves are still 
quite common, both locally and globally; as of 2014, approximately 2.8 billion people used 
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solid fuels, including hardwood, for cooking (121). A study of 170 countries estimated that 
these household fires produced 12% of the global PM2.5, which makes cooking fuels a 
critical point of consideration in the pursuit of improved air quality (121). The impact of 
wood-burning stoves is especially high during cold weather and in colder climates; at least 
11 million homes in the United States use such stoves as heat sources (122).  
 
Rationale for the Study of Prenatal Effects of Wood Smoke Exposure 
 We have previously investigated the effect of in utero cigarette smoke exposure on 
responses to inhaled allergen later in life. This approach provided an opportunity to not 
only establish a causative linkage of disease processes but also dissect the possible 
operative mechanisms (Ferrini, 2017, submitted).  During that study, we found that the 
offspring of pregnant mice exposed to cigarette smoke displayed significantly increased 
allergic inflammatory responses to HDM. This response included exacerbation of airway 
hyperreactivity, pulmonary eosinophilia, mucus production, and cys-LT biosynthesis 
(Appendix 1). Critically, these studies revealed that prenatal exposure to tobacco smoke 
also resulted in: (i) A higher frequency of pulmonary CD11b+ dendritic cells and 
CD3+CD4+ T cells compared to air-exposed mice. (ii) A reduction in the number of 
pulmonary CD3-CD19-NK1.1+CD94+ NK cells. 
These findings complement our reported findings that mice exposed to inhaled 
MWCNT were prone to exacerbated allergic inflammatory responses (Carvalho, 2017, 
submitted). Moreover, these observations raise the possibility of a common underlying 
mechanism for the eliciting of inflammatory responses to inhaled carbonaceous particulate 
material, whether that matter is a complex mixture, such as tobacco smoke, or a much purer 
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exposure, as in the case of MWCNT.  Collectively, these findings form the foundation for 
the current study on wood smoke exposure. Considering the similar properties of wood 
smoke and its significance as a health hazard—both globally and locally—we chose to 
investigate the inflammatory effects of inhaled wood smoke in isolation and in combination 
with allergic stimulus. As in our MWCNT and cigarette smoke studies, we focused on 
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Childhood asthma is strongly linked to atopy and is characterized by a Th2 immune 
response. Both genetic predisposition and environmental factors play key roles in the 
development of allergic asthma, particularly during early life. The molecular mechanisms 
by which such exposures, including air pollutants, can contribute to the development of an 
asthmatic phenotype are poorly understood. We have previously observed that prenatal 
exposure of mice to environmental tobacco smoke is associated with an altered innate 
immune response and enhanced allergen-induced airway inflammation (123) (Ferrini, 
2017; submitted). Given that very little is known with regard to whether in utero wood 
smoke exposure can influence the development of asthma, we devised a controlled murine 
model of prenatal wood smoke exposure to determine the effects on allergic airway disease. 
We used this model to test the hypothesis that: prenatal wood smoke exposure would 
compromise innate pulmonary immune responses resulting in exacerbated HDM-induced 
eosinophilic lung inflammation and increased airway hyperreactivity. In this study, we 
demonstrate that inhalation of wood smoke by pregnant mice results in altered 
inflammatory responses in the offspring. The offspring of female mice exposed to wood 
smoke during pregnancy displayed significantly increased pulmonary inflammation in 
response to HDM challenge as adults compared to offspring of unexposed mice. Offspring 
exposed in utero experienced heightened eosinophilia and elevated biosynthesis of 
cysteinyl leukotrienes in the lung, indicating an exacerbated innate immune response to 





Approximately half of the global population relies on solid fuels, particularly 
biomass such as timber, for cooking and residential heating (124). While this practice is 
often considered a feature of the developing world, woodstoves are also commonly used 
in the European Union, the United States, and other first-world nations (125). Woodstoves 
are in use year-round, but their impact on air quality is particularly severe during cold 
months (126). In winter, products of wood combustion can account for as much as 90% of 
fine particulate pollution in both Seattle, Washington and Christchurch, New Zealand 
(125). Each year, as many as 3.5 million deaths can be attributed to the air pollution 
generated by solid fuel combustion in homes (124).  
 Inhalation of airborne particulates is associated with exacerbation of: asthmatic 
symptoms, allergic responses, pulmonary fibrosis, and lung cancer risk (126). Wood smoke 
inhalation in particular has been linked to increases in the risk of asthma development and 
sensitization to airborne allergens in otherwise healthy individuals (127).  
 The cardinal characteristics of allergic asthma include immune cell recruitment and 
production of IgE in response to inhaled allergen. Initial exposure sensitizes the individual, 
and subsequent exposures to the same allergen can produce severe inflammatory reactions. 
In addition to tissue edema and airway smooth muscle contractions, these reactions are 
characterized by pulmonary eosinophilia. T cells recruited to inflamed airways secrete IL-
5, which is critical to eosinophil recruitment, maturation, and survival; and IL-4, which 
regulates IgE synthesis. IL-13, another T cell-produced cytokine, has been implicated as a 
major inducer of the Th2 response and airway hyperreactivity and remodeling seen in 
allergic asthma. It is also thought to play a role in the recruitment of inflammatory cells 
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(128). Eosinophil chemotaxis in particular is modulated by lipid mediators such as 
cysteinyl leukotrienes (cys-LT), which can be produced by dendritic cells, mast cells, or 
alveolar macrophages (37). Recent experiments in our lab involving cigarette smoke reveal 
that prenatal exposure results in exacerbated allergic inflammation in the offspring after 
birth (123). Although other studies in the field have also suggested eosinophil involvement 
in wood smoke-induced inflammation (127), a detailed characterization of this effect and 
resolution of the operative mechanisms remain unclear.  
 Wood smoke is a commonplace exposure worldwide. However, the processes 
impacted by such exposures and events that make it hazardous remain unresolved. 
Moreover, the specific dangers of wood particulate inhalation remain to be characterized, 
highlighting the importance of delineating the proinflammatory events elicited following 
exposure and making comparisons to other biomass fuels. By elucidating the mechanisms 
by which the inhalation of wood smoke particulate damages pulmonary tissues and impacts 
allergic responses, we are able to improve our current understanding of this pollutant’s 




3.2.3 Materials and Methods: 
Overall Protocol 
 The goal of this study was to develop a controlled mouse model of environmental 
wood smoke exposure and use that model to determine whether prenatal exposure to wood 
smoke will impact innate immunity and airway inflammation elicited by inhalation of 
HDM allergen. The overall design of the experiment was as follows: C57BL/6 mating 
harems (2 dams: 1 sire) were established in our facility and exposed to wood smoke for a 
period of three weeks. On completion of the smoke exposure mothers and newborn pups 
were maintained in filtered cages until the administration of HDM allergen into the airways 
at approximately 8 weeks of age. On day 16 after HDM challenge, lavage and tissue 
samples were collected and the inflammatory response quantified. 
 
Wood Smoke Exposure 
 Our Inhalation Core Facility at the University of Montana houses a Wood Smoke 
Exposure System for investigating the health effects from exposure to wood burning 
emissions. This system is depicted in schematic form in Fig. 3.2. C57BL/6 (wildtype) mice 
breathed normally in a contained environment supplied with either ambient air or a mixture 
of ambient air and larch wood smoke pumped in from a wood-burning stove. Wood smoke 
exposures lasted for three hours each weekday (five consecutive days) for three 
consecutive weeks, totaling 15 days of exposure at a computer-regulated dosage of 3 
mg/m3. This study was designed to model indoor exposures; smoke particulate levels 
average roughly 30-45 µg/m3 in woodstove-heated homes (129). Based on these levels our 
exposures targeted a fine particulate (PM2.5) dose of 3 mg/m3 during gestation of the 
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dams. Our Center has previously reported (130) that comparison of human exposures and 
those in mouse models requires consideration of multiple parameters. Without 
compensating for ventilation rates, lung volume, and body size (“per kg”), identical 
particulate levels would result in significantly lower amounts of deposition in mice. For 
example, a two-hour mouse exposure at a concentration of 10 mg/m3 would deposit 
approximately the same amount as a two-week human exposure at 0.2 mg/m3. This is a 
level well below ranges (190-400 mg/m3) reported for those residing in wildfire areas (131, 
132).  
 
Induction of Allergic Lung Inflammation 
 To assess the long-term effects of prenatal wood smoke exposure on the 
inflammatory response, an acute allergen exposure protocol was used to induce allergic 
lung inflammation. Briefly, the offspring of exposed dams were treated with house dust 
mite (HDM) allergen (Dermatophagoides pteronyssinus extract, Greer Laboratories,) or 
PBS (control) by oropharyngeal instillation over a two-week period. Mice received an 
initial dose of 100 µg HDM on Day 0 followed by two challenge doses of 50 µg each on 
Days 7 and 14. Experimental groups of 4-6 mice were used throughout and experiments 
were performed three times. Blood serum, bronchoalveolar lung lavage fluid (BALF) and 
lung tissue were collected 48 hours after the final HDM exposure (on day 16). Effects on 
the cardinal features of asthma were then assessed. Peribronchial inflammation and mucus-
producing cells were distinguished via lung histology using H&E and PAS staining. BALF 
cell differential counts, eosinophil peroxidase levels, Th2 cytokine production, and serum 
IgE levels were determined as we have described previously (9, 133, 134) using ELISA 
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and flow cytometry (FACSAria II, BD Biosciences US, San Jose, CA) of inflammatory 
cells. The effect of wood smoke exposure on allergic inflammatory responses and cys-LT 
production in the lungs of the dams was also determined and compared with the pups to 
provide a baseline control. The full exposure protocol, including both wood smoke and 
HDM components, is depicted in Fig. 3.3 below. 
 
Intratracheal Administration of House Dust Mite Allergen (HDM)  
To elicit allergic lung inflammation, mice were sensitized to HDM on day 0 by the 
intranasal administration of 100 µg of HDM allergen (Dermatophagoides pteronyssinus, 
Greer Laboratories) in 30 µl of PBS and then on days 7 and 14 by intranasal treatment with 
50 µg of HDM (30µl total volume). HDM allergen preparations used throughout this study 
contained minimal levels of LPS. Control groups comprised mice receiving 30 µl of PBS 
on days 0, 7 and 14. To determine the level of mucosal inflammation, BALF and lung 
tissue were harvested 48h after the last allergen challenge, on day 16.  
 
Determining the Level of Pulmonary Inflammation  
BALF was divided for analysis of cell populations via flow cytometry, cysteinyl 
leukotriene (cys-LT) and cytokine production via EIA and sandwich ELISA, and 
eosinophil peroxidase (EPO) by colorimetric assay.  Lung tissues were reserved for 
histological examination using H&E and PAS. Bronchoalveolar lavage was performed to 
collect bronchoalveolar lavage fluid (BALF) for analysis. Eosinophil peroxidase (EPO) 
levels in the lavage cells were determined by colorimetric analysis using orthophenylene 
diamine dihydrochloride as detailed previously. Cell differential percentages were 
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determined by light microscopic evaluation of Hema3-stained cytospin preparations and 
expressed as absolute cell numbers. Lung tissue was dispersed by collagenase (Type IV; 
Sigma-Aldrich), and lung mononuclear cells (LMC) were isolated by Percoll (Sigma-
Aldrich) density gradient for functional analysis. 
 
Measurement of Cytokines 
BALF chemokine or cytokine levels were determined using ELISA for 
measurement of IL-4, IL-5 (Duoset, R&D Systems) and IL-13 (Quantikine, R&D 
Systems), or using the sensitive Mouse V-Plex Pro-Inflammatory Panel 1 assay and Meso 
Quickplex 120 reader (MesoScale Discovery, MD) for measurement of other cytokines  
(IL-4, IL-5, TNF-α, IFN-γ and IL-12p70).  
 
Histological Determination of Peribronchial Inflammation and Goblet Cell Hyperplasia  
Lung tissue was fixed in 4% paraformaldehyde and embedded in paraffin using a 
Leica ASP 300 tissue processor (Leica, Bannockburn, IL). Microtome sections were cut at 
5µm thickness and stained with hematoxylin and eosin (H&E) using a Shandon Varistain 
24-4 (Thermo Fisher Scientific). Alternatively, sections were stained using periodic acid-
Schiff (PAS) reagent. The level of peribronchial inflammation (H&E stained) or mucus 
production (PAS stained) was analyzed by microscopy and the transmitted light images 
were collected on a Nikon Eclipse 800 microscope equipped with an Olympus DP 26 
camera and cellSens software (Version 1.9).  
 
Measurement of Cysteinyl Leukotrienes 
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BALF was assayed for the presence of cysteinyl leukotrienes (Express ELISA, 
Cayman Chemical, Ann Arbor, MI). IgG present in the BALF was depleted prior to assay 
using Protein G-Sepharose (GE Healthcare Life Sciences). Absorbances were read at 405 
nm (on Spectramax 190, Molecular Devices). 
 
Flow Cytometry 
Cells (LMC, BALF or splenic cells) were FcgR blocked using 2.4G2 antibody 
(ATCC) and stained with combinations of the following mouse conjugated mAb (all 
purchased from BioLegend): allophycocyanin (APC) or FITC anti-CD3, APC/Cy7 anti-
CD4, PE anti-CD8a, APC or PE anti-CD11c, PE or APC/Cy7 anti-I-A/I-E, APC/Cy7 anti-
Ly6G, APC or APC/Cy7 anti-Ly6C, APC/Cy7 anti-Ly-6G/Ly6C (Gr-1), PE, FITC or 
Brilliant Violet 421 anti-CD11b, APC or PE anti-F4/80. In addition, PE anti-Siglec-F (BD 
Biosciences) was used to stain eosinophils. Flow cytometric acquisition was performed on 
a FACSAria II (BD Biosciences) by 4-color analysis using FACSDiVa software and 
FlowJo, with a minimum of 50,000 live, single-cell events per sample collected.  
 
Statistical Analysis 
 Data were analyzed using GraphPad Prism 5.0 (GraphPad, La Jolla, CA). Results 
involving two variables were analyzed by two-way ANOVA with a Bonferroni post-hoc 
test. Data comparing two groups were analyzed using an unpaired t test. Figures show 
combined data from multiple studies or independent repeats (two or more). Data shown are 
mean ± SEM. A p value < 0.05 was considered statistically significant. Significance 
denoted by *, **, or *** is defined as p<0.05, p<0.01, or p<0.005, respectively.  
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3.2.4 Results:  
Effect of Maternal Wood Smoke Exposure on Allergic Inflammation in the Offspring 
 Previous studies have indicated that maternal exposure to airborne pollutants, 
including inhalation of harmful aerosols, predisposes offspring to exacerbated airway 
inflammation (135). However, maternal effects arising from wood smoke exposure have 
not been detailed previously. In addition, the cellular and molecular mechanisms by which 
prenatal exposures contribute to the development of asthma phenotypes are poorly 
understood (136). We assessed whether prenatal wood smoke exposure conferred an 
exacerbated asthma-like phenotype, characterized by peribronchial inflammation and 
goblet cell hyperplasia, in later life. This was examined by determining whether maternal 
exposure to ambient wood smoke affected the allergic responses exhibited by the offspring 
(i.e., in comparison to the offspring of unexposed dams). To visually assess the extent of 
inflammation elicited, we conducted histological imaging of whole lung tissue (Fig. 3.4). 
Histological analysis of lung tissue sections stained with H&E or PAS revealed a marked 
increase in allergen-induced peribronchial inflammation and mucus production in prenatal 
wood smoke-exposed 8-week old offspring compared to the air-exposed controls. Our data 
revealed cellular infiltration, typically forming pockets of inflammatory cells, in the H&E 
stained sections from mice treated with HDM allergen. Notably, the inflamed regions were 
often in proximity to both an airway and a blood vessel. PAS staining of tissue sections 
revealed only low levels of staining of airway epithelial cells in the offspring from both the 
filtered air and wood smoke-exposed dams not sensitized to allergen. In marked contrast, 
the airway epithelial cells in mice instilled with HDM allergen showed significant PAS 
staining. Critically, the offspring of wood smoke-exposed dams that were subsequently 
	 76	
sensitized to HDM allergen displayed dramatically elevated levels of inflammation (and 
PAS staining) compared to filtered air-exposed controls similarly treated with allergen. In 
the absence of HDM sensitization and challenge (baseline controls), negligible 
peribronchial inflammation or mucus production was observed in the lung tissue of both 
wood smoke or air-exposed offspring. Collectively, these observations reveal that prenatal 
exposure to wood smoke increases the severity of the eosinophilic influx and mucus 
hyperproduction elicited by inhaled allergen in later life.  
 In allergic asthma, it is well-documented that CD4+ T cells are involved in the 
airway inflammatory process and likely responsible for disease progression (20-25). The 
size of CD4+ and/or CD8+ T cell populations present in the airways of offspring without 
allergen challenge did not correlate with either prenatal smoke or air exposure. Notably, 
four-fold more CD4+ T cells were present in the BALF of pups born to control dams than 
in the pups of dams exposed to wood smoke (Fig. 3.5a). Similarly, following HDM allergen 
challenge, there were more CD4+ T cells present in the BALF of pups exposed to filtered 
air in utero compared to mice exposed to wood smoke. This phenomenon was repeated in 
the CD8+ T cell populations. Very few CD8+ T cells were present in the BALF of mice 
exposed to wood smoke in utero in comparison to the offspring of control dams. Similarly, 
more than twice as many CD8+ T cells were found in unexposed compared to smoke-
exposed pups after allergen challenge (Fig. 3.5b). Taken together, these observations 
indicate that the allergic responses mounted by mice exposed to wood smoke in utero are 
qualitatively different from the responses displayed by unexposed mice.   
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The Augmented Allergic Inflammatory Responses Caused by in utero Wood Smoke 
Exposure are Impermanent 
 To determine whether the increased responsiveness to HDM allergen conferred by 
in utero exposure to wood smoke was permanent, we conducted a time-course experiment. 
In this experiment, the offspring of wood smoke-exposed mice were retained over 
protracted lengths of time by maintaining in filter-top cages. Offspring were challenged 
over a two-week period with either HDM or PBS (controls) when the mice reached 6, 14, 
or 22 weeks of age. EPO levels generated in BALF were assessed by colorimetric analysis. 
We found that the increase in EPO levels after challenge with HDM allergen was highly 
significant (***p<0.001) in the 8-week-old pups of wood smoke-exposed mice compared 
to 8-week-old pups of control mice (Fig. 5a). This elevation persisted through the 16-week 
time-point; although the eosinophilia in WS/HDM offspring had by this time decreased, 
the difference remained statistically significant (**p<0.01) (Fig. 3.6b). By the time the 
mice were 24 weeks old there was no significant difference detected between EPO levels 
in Air/HDM mice and WS/HDM mice (Fig. 3.6c). These data reveal that the exacerbated 
immune response observed in the offspring of smoke-exposed dams is not retained as the 
mice age. 
 
The Effect of Exposing Pregnant Mice to Wood Smoke on their Responsiveness to HDM 
Allergen 
 It has been proposed that inhalation of particulate mixtures, such as smoke, has 
adverse consequences to health (126, 137-141). Epidemiological data has further implied 
a particularly high risk of such effects in pregnant women (142-144). Since wood smoke 
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exposure exerted pronounced effects in the offspring, it was important to ascertain whether 
this exposure also impacted maternal responses to allergen. This could only be done after 
the dams had delivered and cared for their offspring (i.e., until after weaning, typically 4 
weeks after delivery). Four weeks after delivery, dams were challenged with HDM allergen 
and the level of allergic inflammation that developed in response was determined. 
Comparisons were made with allergen-challenged filtered air-exposed dams. Challenge of 
post-delivery females with HDM allergen resulted in increased levels of lung inflammation 
compared to filtered air control mice.  
Firstly, measurement of EPO by colorimetric assay demonstrated a significant 
increase in the number of eosinophils in the airways of both control and smoke-exposed 
dams sensitized to HDM allergen compared to PBS controls (Fig. 3.7a). Importantly, there 
was also significant elevation of eosinophil infiltration in wood smoke-exposed, allergen-
sensitized mice compared to filtered air-exposed, allergen-sensitized mice.  Secondly, flow 
cytometry revealed that the frequency of CD11b+/F4-80-/Siglec-F+/GR-1- eosinophils 
present in the BALF was ten percent higher in mice exposed to both smoke and allergen 
than in mice exposed only to smoke, and more than twenty percent higher than mice 
exposed only to allergen (Fig. 3.7b). Thirdly, cysteinyl leukotriene levels (measured by 
EIA) were elevated in mice exposed to both smoke and allergen, being more than five-fold 
higher than in mice exposed only to smoke (Fig. 3.7c).  
Lastly, to examine whether T cells play a role in the exacerbation of allergic 
inflammation arising from wood smoke exposure, we examined the number of CD4+ and 
CD8+ T cells present in the BALF. CD4+ T cells were detected in greater numbers in the 
airways of dams exposed to wood smoke in than in air controls; however, fewer CD4+ T 
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cells were counted in dams exposed to both wood smoke and HDM in comparison to those 
sensitized to HDM without smoke (Fig. 3.8a). CD8+ T cell counts followed the same 
pattern, with smoke exposure alone elevating the population while the addition of allergen 
to smoke-exposed dams decreased cell numbers to fewer than those elicited by allergen 
alone (Fig. 3.8b). This data suggests that direct inhalation of wood smoke may result in 
elevated CD4+ and CD8+ T cell counts, which are depressed during subsequent immune 
responses to allergen. Collectively, these observations reveal that inhalation of wood 
smoke while pregnant exacerbates allergic inflammation in adult females after delivery of 
offspring. 




Health Consequences of Exposure to Airborne Particulate Matter 
  Inhalation of airborne particulate matter has been shown to be detrimental to 
cardiopulmonary and respiratory health (145-147), resulting in increased variability of peak 
expiratory flow volume (PEF) in asthmatic individuals (148). Also, increased hospital 
admissions for respiratory and cardiac conditions inclusive of asthma (137, 149), increased 
risk of bacterial and fungal infection (147, 150), and increased rates of all-cause mortality 
have all been linked to exposure to airborne particulate matter. Collectively, these 
observations have led researchers in the field to conclude that such pollution has a 
significant impact on public health (151). It has also been observed that airborne particulate 
matter, particularly the fine fraction, contains carcinogens including PCBs, PAHs, and 
transition metals (108, 147, 152, 153).  
Furthermore, maternal exposure to tobacco smoke during pregnancy has been reported 
to increase the risk of asthmatic development in the child (135). This indicates that there is, 
beyond the nonspecific risk during gestational development, a capacity for maternal 
respiratory exposures to have a significant impact on the immune responses of offspring. 
Significantly, cigarette smoke exposure during pregnancy has been reported to induce 
epigenetic changes that are responsible for augmented inflammatory responses (Ferrini, 
2017; submitted).  
Wood smoke is of particular concern as a widespread source of PM2.5. The sources of 
such smoke—woodstoves, wildfires, and scheduled burns—are a global problem. Exposure 
to the combustion products of household fuels alone impacts nearly 3 billion people 
worldwide in more than 170 countries (121), including upwards of 11 million households 
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in the United States (122), and accounts for an estimated 12% of the world’s air pollution 
(121). Inhalation of wood smoke has been strongly associated with the incidence of 
childhood asthma, asthma morbidity, and severity of asthmatic symptoms (131, 148, 154-
157). Evidence suggests that wood smoke exposure can impact lung innate immunity. The 
primary cellular targets of this change have thus far appeared to be alveolar macrophages 
and lung epithelial cells (158, 159). This is reasonable, given that these cells have easy 
access to the airway and that PM2.5 particles are able to penetrate deeply into the lung. 
 
Murine Model of in utero Wood Smoke Exposure  
This study revealed that exposure of pregnant females to wood smoke resulted in the 
generation of offspring that displayed augmented inflammatory responses to inhaled HDM 
allergen. The events underpinning this effect remain largely unresolved. In part this is 
because the events elicited by both wood smoke and allergen are likely complex and 
multifactorial. With respect to HDM allergen, it is known that this allergen both promotes 
the differentiation of CD4+ Th2 cells and activates ILC2s (24, 101). Both of these events 
contribute to the development of pulmonary eosinophilia (89, 160, 161) (Fig. 3.9).	 
In marked contrast to in utero cigarette smoke exposure, where the augmented 
responsiveness in the offspring was stable over the four-month observation period (Ferrini, 
2017; submitted), the exacerbated allergen responses caused by in utero wood smoke 
exposure were progressively lost as the offspring aged. It is conceivable that this effect may 
result from: 
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(i) Smoke-induced epigenetic gene regulation events that are reversed over time 
(123, 162). Smoke-induced epigenetic changes in early life could promote ILC2 
and/or CD4+ Th2 responses in later life (163-165). 
(ii) Smoke-induced changes in the immune cells present in the lungs of the 
offspring. Increased HDM responses could arise from elevated CD4+ T cells, 
antigen presenting cells, or ILC2s. 
(iii) Smoke-induced retardation of fetal lung development resulting in associative 
changes in lung mucosal immune function. In this respect, epidemiological 
studies of human populations have indicated that maternal exposure to PM2.5 
during pregnancy is positively correlated to preterm birth, low birth weight, and 
poor respiratory outcomes; exposure is also correlated with intrauterine 
inflammation, which is a known risk factor for these conditions (142, 143). 
There is also evidence that chronic maternal inflammation, such as asthma, 
effects alterations to the placenta and fetus, including low birth weight, preterm 
birth, and neonatal hospitalization (144). Asthmatic exacerbations are 
particularly dangerous to the developing fetus and are associated with increased 
risk of stillbirth by way of maternal alkalosis, reduced levels of maternal 
oxygen, and increased oxidative stress (144). From these studies, we can deduce 
that maternal exposure to inflammatory stimuli and subsequent immune 
responses to these stimuli have a consistently negative impact on the viability 
of the fetus. 
 
Effect of Wood Smoke Exposure on Maternal Lung Function 
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When considering potential mechanisms responsible for augmented allergen responses 
in the offspring, the finding that exposure of pregnant dams to wood smoke resulted in 
augmented respiratory inflammation is important. Specifically, pregnant female mice 
exposed directly to wood smoke over a period of three weeks displayed significantly 
increased recruitment of CD11b+/F4/80-GR-1- eosinophils and biosynthesis of cys-LT in 
the airways following HDM allergen sensitization compared to allergen-sensitized mice that 
were not exposed to wood smoke. This eosinophilia and cys-LT elevation coincided with 
increased mucus secretion, as identified through PAS staining of lung tissue. These findings 
in adult female responses would seem to argue against the possibility that wood smoke 
effects are solely consequences of retarded fetal lung development (i.e., (iii) above).  
 
Potential Contributors to Smoke-Induced Exacerbations of Inflammation 
(i) Similarity to MWCNT exposures. An important consideration is that the 
exacerbation of maternal allergic lung inflammation by wood smoke bears 
some similarities to exacerbations elicited by the introduction of MWCNT. This 
may be due to physical similarity between nanoparticles and the PM2.5 
contained in wood smoke, as both have been previously shown to be of 
sufficiently minute size to deposit in the bronchial and, on the finer end of the 
scale, alveolar spaces (108). It has further been observed that some of the 
combustion products encompassed within the PM2.5 metric are themselves 
naturally-occurring nanoparticles (46) and may thus be reasonably expected to 
behave similarly to engineered nanoparticles. However, having recently 
examined the effects of MWCNT on lung inflammation (Carvalho, 2017, 
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submitted), we theorized that wood smoke particulate might also impact the 
respiratory immune response through the recruitment of eosinophils and 
biosynthesis of cys-LT. Metal content should also be considered. Many 
engineered nanoparticles contain residues of the transition metal catalysts used 
in manufacture; these residues have been proposed as one source of ENM 
immune reactivity (Carvalho, 2017, submitted). Toxic metals have also been 
identified as components of particulate aerosols arising from both wood burning 
and other sources (152, 153, 166).  
(ii) Cys-LT production. It is possible that the increased eosinophilia associated with 
wood smoke inhalation may be a consequence of elevated cys-LT synthesis, 
potentially involving metal contaminants. This theory could be tested via the 
introduction of 5-lipoxygenase (5-LO) inhibitors to the exposure model.  
(iii) Allergen-specific CD4+ T cells. Our data also indicated that the wood smoke 
inhalation by pregnant adult female mice had little effect on the numbers of 
CD4+ and CD8+ T cells present in the airways. Fewer T cells were found in the 
BALF of those mice sensitized to allergen than in unsensitized dams, regardless 
of whether they had previously been exposed to wood smoke or not. The 
difference in T cell counts between allergen-sensitized mice and their non-
sensitized counterparts was less than two-fold. Conversely, the numbers of 
CD4+ T cells recovered from the pups of smoke-exposed dams increased by 
nearly ten-fold from control with the introduction of allergen (1933 in 
WS/HDM vs. 201 in WS/PBS). In comparison in the pups of air-exposed dams, 
the CD4+ T cell population more than doubled following allergen challenge 
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(2197 in Air/HDM vs. 888 in Air/PBS). As observed in the dams themselves, 
these trends persisted in the numbers of CD8+ T cells in the offspring. This is 
particularly intriguing in the context of allergic asthma, which is commonly 
characterized by an elevated CD4+ Th2 response. It is worth noting that despite 
the shared overall trend in CD4+ T cell numbers between air-exposed pups and 
smoke-exposed pups, the latter group expressed fewer cells in the BALF 
regardless of allergen sensitization. However, the dramatic expansion of the 
pups’ CD4+ T cell population following sensitization of smoke-exposed 
offspring to HDM suggests that the maternal smoke exposure has primed the 
pups’ immune systems to respond to allergic stimuli. These observations are 
supportive of the hypothesis that elevated lung CD4+ Th2 responses underpin 
the increased pulmonary eosinophilia observed in mice experiencing in utero 
wood smoke exposure. 
 
Summary 
The data obtained from this study present two novel conclusions.  Firstly, we have 
shown evidence that introduction of wood smoke to the lungs of adult mice results in 
elevated eosinophilia and cys-LT biosynthesis, and this likely constitutes a shared 
inflammatory mechanism with respiratory exposure to MWCNT. Secondly, we have 
demonstrated that the exposure of pregnant females to wood smoke not only elicits 
respiratory inflammation in the dams themselves, but also impacts the development of T 
cell-mediated immunity in the offspring in such a way as to distinctly heighten the pups’ 
responsiveness to allergen.  
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Figure 3.2  
Illustration of the wood-burning apparatus and inhalation system. 
Smoke was piped from a wood-burning stove into sequential dilution chambers where it 
was mixed with filtered outside air before being carried into the exposure chamber. Custom 








Figure 3.3  
Protocol for exposure of dams to inhaled wood smoke and sensitization of pups to 
HDM via oropharyngeal aspiration.  
Pregnant C57BL/6 mice in homeboxes were placed in the smoke exposure chamber and 
allowed to respire normally for 3 hours, inhaling either wood smoke or filtered air, each 
day for 5 days a week for a period of 3 weeks. Following 8 weeks of maturation, the pups 
of exposed dams were given an initial 100 µg sensitization dose of HDM suspended in PBS 
on day 0 and two 50 µg challenge doses on day 7 and day 14. Control/sham-treated mice 
were given filtered air and PBS in place of wood smoke and HDM. All pups were harvested 






Figure 3.4  
Histological imaging of lung tissue from mice prenatally exposed to wood smoke and 
subsequently challenged with HDM. 
 Following euthanasia and harvest, lung tissue was embedded in paraffin and sectioned at 
5 µm thickness. Sections were stained with H&E for visualization of respiratory 
inflammation or with PAS for imaging of mucus production and goblet cell hyperplasia. 
Sections for each experimental group were taken from 4 representative mice, aged 8 weeks. 
Control groups: offspring of pregnant females exposed to filtered air instead of wood 
smoke and PBS instead of HDM; lung sections stained with H&E (a) and PAS (e). Allergen 
groups: offspring of pregnant females exposed to filtered air instead of wood smoke; pups 
were later sensitized to HDM allergen as adults. Lung sections stained with H&E (b) and 
PAS (f). Wood smoke groups: offspring of pregnant females exposed to controlled levels 
of PM2.5 in wood smoke; pups were later dosed with PBS in place of HDM. Lung sections 
stained with H&E (c) and PAS (g). Dual-exposure groups: offspring of pregnant females 
exposed to controlled levels of PM2.5 in wood smoke; pups were later sensitized to HDM 














Figure 3.5  
Impact of prenatal wood smoke exposure on T cell involvement in allergic responses 
of adult offspring. 
 Dams inhaled either filtered air or controlled levels of PM2.5 in wood smoke for 3 hours 
per day, 5 consecutive days per week, over the course of 3 consecutive weeks. Following 
birth and natural weaning, pups were maintained for 6 weeks before being sensitized to 
HDM according to our established model of asthmatic inflammation. Pups (6 per group) 
were intranasally challenged with HDM allergen or PBS (control). Bronchoalveolar lavage 
fluid (BALF) was collected for analysis by flow cytometry. Lymphocytes were gated 
according to size, granularity, and expression of CD3 to identify T lymphocytes. CD4+ (a) 




Figure 3.6  
Prenatal exposure to wood smoke promotes exaggerated eosinophilia in response to 
allergen, and the magnitude of this response decreases over time. 
C57BL/6 mice were prenatally exposed to filtered air or wood smoke; they were then 
sensitized to HDM allergen or dosed with PBS at 6, 14, or 22 weeks of age. EPO levels in 













Figure 3.7  
Impact of wood smoke exposure on eosinophilia and cysteinyl leukotriene 
biosynthesis in the airways of adult female mice.  
Mice inhaled either filtered air or controlled levels of PM2.5 in wood smoke for 3 hours per 
day, 5 consecutive days per week, over the course of 3 consecutive weeks. Following birth 
and natural weaning of pups, dams were sensitized to HDM according to our established 
model of asthmatic inflammation. Dams (6 per group) were intranasally challenged with 
HDM allergen or PBS (control). Bronchoalveolar lavage fluid (BALF) was collected for 
analysis. Relative degrees of eosinophilia were determined by colorimetric assay of EPO 
recovered from BALF supernatant (a).  Portions of supernatant were also analyzed via flow 
cytometry (b). Leukocytes identified as CD11b+ and F4/80- were further separated 
according to expression of Siglec-F and GR-1. Those being Siglec-F+ and GR-1- were 
identified as airway eosinophils. To gauge involvement of cysteinyl leukotrienes in relation 
to increased eosinophilia, BALF supernatant was further examined by EIA kit, according 
















Figure 3.8  
Impact of wood smoke exposure on T cell involvement in allergic responses of adult 
female mice.  
Dams inhaled either filtered air or controlled levels of PM2.5 in wood smoke for 3 hours per 
day, 5 consecutive days per week, over the course of 3 consecutive weeks. Following birth 
and natural weaning of pups, dams were sensitized to HDM according to our established 
model of asthmatic inflammation. Dams (6 per group) were intranasally challenged with 
HDM allergen or PBS (control). Bronchoalveolar lavage fluid (BALF) was collected for 
analysis by flow cytometry. Lymphocytes were gated according to size, granularity, and 
expression of CD3 to identify T lymphocytes. CD4+ (a) and CD8+ (b) T cells were 






Fig. 3.9  
Proposed mechanisms of inflammation exacerbation pursuant to wood smoke 
exposure.  
Wood smoke inhaled by pregnant dams activates the airway epithelium, which 
subsequently secretes ILC2-inducing cytokines and potentially cys-LT, which activate Th2 
cells. These factors influence the developing fetus. When grown offspring are later 
sensitized to HDM allergen, their airway epithelial cells respond vigorously and activate 
Th2 cells and ILC2s. These cells release cytokines conducive to the recruitment of 




4.0 Overall Conclusions and Future Directions 
4.1 Conclusions 
Allergic asthma is a complex and chronic inflammatory disease of the airways that 
affects more than 300 million people worldwide. It is of particular concern in highly 
populated regions of the globe, which include both North and South America, where almost 
85% of asthmatics are allergic to house dust mite (66, 67). Asthma is characterized by 
airway hyperreactivity, contraction of the smooth muscle, goblet cell hyperplasia, 
increased mucus production, and eosinophil recruitment. While a great deal of research has 
been performed to determine the cellular and molecular processes underlying these aspects 
of the disease, much remains to be discovered. One particular need centers on developing 
a better understanding of the effect of airborne particulate exposures on the severity of 
asthmatic inflammation.  
To address this gap of knowledge, we examined the relationships between the 
inflammatory processes central to allergic asthma using two model exposures: multi-
walled carbon nanotubes and wood smoke. Inhalation of MWCNT is largely an industrial 
occupational exposure, as materials containing MWCNT are well-suited to numerous 
applications ranging from electronics to medical implants, but nanoparticles are much less 
likely to be aerosolized after manufacture (62). Wood smoke, by contrast, is mainly a 
household exposure. Wood-burning stoves are still quite common, both locally and 
globally; as of 2014, approximately 2.8 billion people used solid fuels, including 
hardwood, for cooking (121). Together, MWCNT and wood smoke constitute potential 
pulmonary health hazards to many people of all ages and demographics. Furthermore, 
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studying these exposures offered opportunities to better characterize their adverse health 
effects and to improve our understanding of how those impact inflammatory mechanisms. 
Our studies demonstrated that introduction of nickel-containing MWCNT to the 
lung after HDM allergen sensitization results in significantly exacerbated inflammatory 
responses. Specifically, sensitized mice instilled with FA21 displayed augmented 
eosinophilia and elevated biosynthesis of cysteinyl leukotrienes. This is suggestive of a 
causative role for cys-LT in the recruitment of eosinophils to the airways; dissecting the 
full mechanism of this action will require further study. Interestingly, our investigation into 
the interaction of allergic inflammation and wood smoke exposure may offer another 
avenue of exploration into that process. Adult female mice exposed to ambient wood 
smoke for a period of three weeks prior to HDM sensitization displayed significantly 
increased eosinophilia and cys-LT production after allergen challenge. Furthermore, the 
offspring of those mice, having been exposed to wood smoke only in utero, experienced 
the same effect: augmented eosinophil recruitment and biosynthesis of cys-LT. These 
observations indicate the possibility of a single mechanism of lung eosinophil recruitment, 
mediated by cys-LT, which is activated by inhalation of carbonaceous particulate 
regardless of source.  
 Collectively, the studies detailed in this manuscript have supplied novel insights 
into the connections between inhaled pollutants and pulmonary allergic inflammation. 
These data help to advance our understanding not only of the harmful impacts of MWCNT 
and wood smoke on the body, but also of the cellular processes underlying inflammation 
in allergic asthma. 
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4.2 Future Directions 
Several aspects that contribute to pulmonary inflammatory responses to inhaled 
MWCNT, wood smoke, and the delineation of similarities between these remain 
unresolved. Additional experiments are needed to further dissect molecular events 
contributing to the effects of particulate exposures. 
 
4.2.1 Unresolved Issues Pertaining to MWCNT-Induced Airway Inflammation 
A major hope when investigating the inflammatory properties of MWCNT is that 
specific parameters may be defined which prove to be predictive of the host response to 
the particle. The most notable factors influencing the host response to these particles were 
the presence of nickel in the particle and the production of cys-LT in the airway. 
(i) The presence of nickel clearly correlated with the particles’ inflammatory 
potential. To further evaluate the inflammatory response elicited by different 
MWCNT particles containing different levels of residual nickel catalyst, 
additional experiments could be performed either by removing the metal from 
Nihigh particles like FA21 or by supplementing it in preparations of Nilow 
particles like FA04. The nickel present in FA21 is likely covalently bound into 
the particle, making removal of the metal difficult. Whether acid washes 
remove the metal (to be assayed by ICP mass spectrometry) and thereby the 
resultant effect on inflammatory potential would be interesting. Alternatively, 
the effect of adding the metal back to FA04 could be addressed by simply 
adding it to the dispersion media prior to sonication. 
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(ii) Inhibitors of 5-LO reduced the lung inflammatory response elicited by FA21. 
The principal aspects that remain unresolved pertain to the cellular source of 
the observed leukotrienes and the relative contributions of LTB4 and cys-LT 
(both products of arachidonic acid by action of 5-LO) to the inflammatory 
process. Mice lacking LTB4 receptors (BLTR1 and 2) would subsequently 
serve as an approach to resolve their relative importance. This would be 
addressed by evaluating the respective levels of LTB4 and cys-LT present in the 
BALF after instillation of MWCNT. More definitive involvement of these 
mediators could also be ascertained by administering MWCNT to 5-LO -/- mice 
(obtained from Jackson Labs). 
(iii) Prenatal exposure to wood smoke has profound effects on the pulmonary 
inflammation elicited by HDM allergen in later life. This observation raises the 
possibility that prenatal exposure to MWCNT might mediate a similar effect. 
In these experiments, dams would be exposed to MWCNT and their pups would 
be evaluated for signs of exacerbated inflammatory responses.   
 
4.2.2 Unresolved Issues Pertaining to Wood Smoke-Induced Airway Inflammation 
The maternal exposure to wood smoke clearly had profound consequences for 
allergen responsiveness in the offspring. However, several issues remain unresolved, 
largely as a consequence of the inherent complexity of this model. They include: 
(i) Develop a more detailed characterization of the cellular events that underpin 
the elevated HDM-responsive inflammation resulting from in utero exposure to 
wood smoke. The relative roles of ILC2 and CD4+ Th2 cells and their 
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associated cytokines (IL-4, IL-5, IL-9, and IL-13) need to be resolved. The 
relative contributions of ILC2 and CD4+ T cells could be initially investigated 
by exposing pregnant IL-13 and IL-5 reporter mice to wood smoke and 
monitoring the cellular sources of these cytokines in the offspring, using both 
control (steady-state) and HDM-sensitized mice. 
(ii) Examine the BALF collected from mice exposed to wood smoke in utero for cys-
LT and LTB4 levels. The effect of treating dams with 5-LO inhibitors during 
wood smoke exposure should provide information as to the value of these 
mediators in conferring the observed exacerbated responsiveness to HDM 
allergen to the offspring. Antibodies exist to permit flow cytometry analysis of 
CysLT1. It may also be possible to stain receptors and leukotrienes for 
colocalization via confocal microscopy, though the short half-lives of most cys-
LT would likely limit this method to the study of LTE4. 
(iii) Isolate the component of wood smoke most critical to exacerbating HDM 
responsiveness to the offspring. This would rely on a dose-response study of 
varying concentrations of PM2.5 to experimentally determine the most 
hazardous concentrations and thereby improve the model’s relevance to real-
world exposures. It would also be necessary to resolve the relative roles of the 
gaseous and particulate phases of wood smoke by improving their 
characterization. Namely, it may be possible to fractionate the smoke and 
examine independently the effects of PM10 and the gaseous components in 
addition to those of PM2.5. 
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(iv) Assess the effects of wood smoke exposure on fecundity. While conducting our 
wood smoke study, we observed what appeared to be unusually large litters 
produced by smoke-exposed dams. This bears further investigation to 
determine whether wood smoke inhalation somehow impacts litter size and if 
so, how. 
(v) Investigate the role of maternal milk in conveying altered immunity from wood 
smoke-exposed dams to pups. The event responsible for the observed skewing 
of immunity toward Th2 responses following wood smoke exposure remains 
unclear. It is possible that potentiation of allergic inflammatory responses in the 
progeny may occur in neonates via immunologically active factors present in 
maternal milk. The possibility that maternal immune modulatory factors are 
transferred in the colostrum to offspring during lactation has been demonstrated 
previously and asthma susceptibility in humans can be conferred by breast milk. 
To test the potential contribution of milk-borne mediators, we will examine the 
effect of adoptive nursing in our model of wood smoke exposure and allergen 
sensitization. Litters of C57BL/6 mice will be swapped between smoke-
exposed and air-exposed dams within 24 hours of birth. 
(vi) Determine whether maternal exposure to wood smoke retards development of 
the lung and associated innate immunity in the offspring. This may manifest 
itself in elevated numbers of lung ILC2s or dendritic cells. To resolve this 
possibility, one possible strategy would involve harvesting pups immediately 
after birth and comparing cellular indicators of development in the BALF and 
the lung epithelium.  
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4.2.3 Inflammatory Mechanisms Common to MWCNT and Wood Smoke Exposures 
 Additional experiments will seek to examine whether common inflammatory 
events contribute to both MWCNT and wood smoke. Given the important role that nickel 
played in our nanotube studies, further investigation is warranted into its function in wood 
smoke-induced pulmonary inflammation. This would involve characterizing the metal 
content of wood smoke via ICP-mass spectrometry and empirically evaluating the 
differences between nickel-bearing MWCNT and purified MWCNT. To gain insight into 
the processes by which residual nickel catalyst becomes chemically available in vivo, 
powdered nickel could be added to a preparation of nickel-free MWCNT prior to 
sonication. A second area worthy of investigation is whether the action of cys-LT detailed 
in the MWCNT study also plays a central role in smoke-induced exacerbations of 
inflammation. If this assertion were found to be correct, then the next logical step would 
be to resolve whether cys-LT are operative in the dams or in their offspring. Lastly, 
investigations by our laboratory have revealed that NK cells are involved in suppressing 
the development of HDM-induced lung inflammation. Conceivably, the elevated 
responsiveness arising from either exposure could be a result of diminished numbers or 
functionality of pulmonary NK cells. It would be interesting to detail the behavior of NK 
cells in both models and to determine the extent of NK cells’ role following direct and 




A Role for PGI2 in the Maturation of Hepatic NK Cells 
 
Abstract: 
During the characterization of mice lacking the PGI2 receptor, IP, it was observed 
that the most overt characteristics of the IP-/- mice were changes in the NK cells present 
in these animals. These changes included a marked increase in the level of NKp46 
expression by NK cells in the spleen and lungs. During the course of this study we 
examined the level of cytokine expression by NK cells in IP-/- mice compared to WT 
controls. We reported that the level of IFNg produced in response to NK1.1 cross-linking 
by splenic NK cells was elevated in IP-/- mice. The liver has been reported to contain large 
numbers of NK cells, including one population which is resident in the tissue and another 
indistinguishable from circulating NK cells. Given that the number and characteristics of 
lung tissue NK cells were altered in IP-/- mice, we examined whether such differences 
were also evident in the liver. Comparison of surface phenotypes and cytokines produced 
by NK cells in IP-/- and WT mice revealed that hepatic NK cells were more numerous in 
IP-/- mice. Activation of hepatic mononuclear cells using immobilized NK1.1 in the 
presence of exogenous IL-2 failed to induce significant levels of IFNg secretion in either 
IP-/- or WT cells. These findings suggest that the livers of the IP-/- mice contain elevated 
of NK cells, but these cells were atypical since they did not produce IFNg. Whether this 
was an artifact of collagenase dispersion or an inherent property of these NK cells remains 
unclear. In addition, the hepatic T cells in C57BL/6 mice produced over five-fold more 
	 107	
IFNg than was produced by IP-/- T cells. These findings reveal major differences in both 





Natural Killer Cells 
Natural killer (NK) cells are a unique innate lymphocyte population that acts as part 
of the first line of host defense.  These cells are employed to kill virus-infected or malignant 
cells and accordingly play an important role in tumor defense (167).  Approximately 10% 
of resident lymphocytes in the lung are NK (168).  These are characterized as 
CD11bhighCD27low and express higher levels of DX5, CD122, Ly49s, and CD43 than do 
splenic NK (169).  The rapid response time of lung NK and their ability to bridge the gap 
between innate and adaptive immunity make them ideally suited to combatting respiratory 
infections. NK depletion has been demonstrated to reduce the efficiency of pathogen 
clearance, worsen lung pathology, and decrease the Th1 population (168).  This suggests 
that NK cells are central to the induction of protective immunity in the lung, which can 
also be influenced by prostacyclin-IP signaling.  
 Conventional NK cells (cNK) arise from a common lymphoid progenitor in the 
bone marrow.  Immature NK express NK1.1 at later stages of development; this is followed 
by the expression of NKp46 and subsequently DX5, which appears immediately prior to 
NK maturation and departure from the bone marrow.   Mature NK go through an additional 
four developmental stages, which can be distinguished according to varying levels of 
CD11b and CD27 expression. 
Though it has long been believed that NK cells are limited to nonspecific immune 
functions (170), more recent studies have presented evidence that they possess a degree of 
immunological memory.  NK cells can modulate elements of adaptive immunity 
independent of T and B cells, as observed in a murine model of contact hypersensitivity: 
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Rag2-/- mice were capable of mounting an adaptive immune response to hapten challenge 
despite the absence of T and B lymphocytes, but were rendered incapable of this following 
depletion of NK cells.  These studies identified the surface expression of Thy-1, Ly49C, 
and CXCR6 as markers for so-called memory NK cells in mice, along with the absence of 
DX5.  In humans, sensitized memory NK cells have been shown to produce increased 
amounts of IFNγ when activated by IL-12, IL-15, and IL-18 (171).  NK cells also interact 
closely with dendritic cells (DC). Activation of NK induces maturation of the DC through 
mechanisms dependent on TNFα, IFNγ, and cell-to-cell contact.  Mature DC, in turn, 
support the polarization of T cells to favor the Th1 response and decrease inflammation 
(168). 
NK cells are a major source of IFNγ throughout the body.  IFNγ is an important 
effector molecule for anti-viral responses and also plays a role in regulating other immune 
functions. It is therefore considered likely that IFNγ is closely involved with the 
immunological tolerance observed in the liver (172).  IFNγ is also known to be a central 
component of the inflammation involved in delayed-type hypersensitivity (173). 
Traditionally thought to be made exclusively by NK and T cells, IFNγ has more recently 
been identified as a product of innate immune cells, including macrophages, DC, and 
neutrophils, as in the case of hypersensitivity pneumonitis.  Synthesis of IFNγ by innate 
cells is key to the establishment of Th1 responses before T cells begin production as part 
of the adaptive immune response (174). 
 
Hepatic Natural Killer Cells  
	 110	
NK cells make up approximately 40% of all lymphocytes present in the liver.  
Liver-resident NK are functionally and phenotypically distinct from those circulating in 
the blood; hepatic NK are involved in viral defense, tumor suppression, and fibrosis 
prevention.  The main site of NK cell development is the bone marrow, in both mice and 
humans (171).  But the source of liver-resident NK cells is still unclear; they may originate 
in the liver itself or mature from precursors arising in the bone marrow. Two phenotypically 
different populations of NK cells have been described in the livers of mice. One population 
is CD3-CD19-NK1.1+DX5+ and indistinguishable from circulating NK cells, while the 
other is CD3-CD19-NK1.1+DX5- and believed to reside in the liver without entering 
circulation. 
While conventional NK cells are present in the liver, nonconventional trNK cells 
also appear.  trNK cells are CD49a+DX5-, whereas cNK are CD49a-DX5+.  Unlike cNK, 
trNK develop in the absence of the transcription factors NFIL3 and Eomes.  Instead, trNK 
rely on T-bet, which is expressed at an earlier point in development in the liver than in the 
bone marrow; this yields mature NK deficient in DX5.  This suggests that trNK may arise 
from a developmental pathway distinct from that of bone marrow derived cNK.  Both cNK 
and trNK in the liver produce IFNγ and are capable of releasing perforin and granzymes; 
however, trNK also produce TNFα, which stimulates the recruitment of neutrophils to the 
liver (169). 
The liver is integral to both innate and adaptive immunity. It is a site of extrathymic 
T cell proliferation, development of immunological tolerance, and deletion of activated T 
cells (175).  The hepatic environment favors the induction of tolerance over immunity 
when exposed to foreign antigens.  This sets the liver apart as an immune-privileged site, 
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wherein allografts, certain pathogens, and exogenous proteins are for the most part 
immunologically ignored.  This local tolerance often begets systemic tolerance of those 
antigens which are persistently expressed in the liver.  The tolerogenic mechanism has 
therapeutic implications in that hepatic expression of autoantigens can significantly reduce 
the incidence of autoimmune diseases (172). 
Even though the liver cedes much of its hematopoietic ability to the bone marrow 
as the animal ages, the adult human liver does retain the capacity to resume hematopoiesis. 
This may make it possible for resident NK to originate directly from the liver. However, 
there is also evidence that tissue-resident NK develop from precursors originating in the 
bone marrow. Hepatic NK precursors are swiftly replaced by precursors recruited from the 
bloodstream if depleted, as in the case of liver transplants. Contrarily, mature NK do not 
leave the hepatic tissue to reenter circulation. This suggests that while NK cells may 
originate in the bone marrow, they remain stationary after migrating to the liver and 
maturing there (176).   
 
PGI2 Receptor, IP, and NK Cells  
The IP receptor and its ligand, prostacyclin (PGI2), have been shown to be involved 
in the development of hypersensitivity reactions such as contact dermatitis and allergic 
asthma in both humans and mice (96). Like all prostanoids, prostacyclin is a bioactive lipid 
derived from arachidonic acid through the enzymatic activity of cyclooxygenases. 
Prostacyclin in particular has been examined due to its vasodilatory function and its 
capacity to prevent aggregation of platelets. These studies have led to the creation of a 
number of synthetic analogs (177).  Those analogs have in turn been found to possess the 
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ability to suppress Th2 responses, including bronchoconstriction and the recruitment of 
Th2 cells to airways, thereby significantly decreasing Th2-type inflammation.  
Furthermore, IP deficiency can exacerbate Th1 responses, leading to increased viral 
inflammation and elevated production of IFNγ by T cells (178).  
As the Th2 response is central to the progression of allergic asthma, the potential 
of prostacyclin-IP signaling to modulate related symptoms bears further investigation. To 
that end, we have previously examined this receptor and described a disparity in the innate 
immune responses of C57BL/6 vs. IP-/- mice (69). Most notable was the difference in 
populations of NK cells in the lungs and spleen, with the lung of mice deficient in the 
prostacyclin receptor containing roughly twice as many NKs as those of wildtype mice.  
As the liver is home to large numbers of NK cells, we examined the relative populations 







C57BL/6 (The Jackson Laboratory, Bar Harbor, ME) (10-16 weeks old) were used 
throughout this study. Mice were bred under pathogen-free conditions in a barrier facility 
and experimental animals maintained in micro-isolator cages and treated in accordance 
with National Institutes of Health guidelines and the American Association of Laboratory 
Animal Care regulations. Animal experiments were approved by the University of 
Montana, Institutional Animal Care and Use Committee, IACUC according to National 
Institute of Health guidelines.  
 
Media  
Cells were cultured in RPMI 1640 supplemented with 10% fetal bovine serum 
(CM-RPMI), (Hyclone Fetal Calf Serum, Thermo Scientific), L-glutamine, penicillin & 
streptomycin, HEPES, Sodium Pyruvate (Gibco Life Technologies) and 2-
mercaptoethanol (Sigma-Aldrich, St. Louis, MO).   
 
Isolation of Hepatic Immune Cells  
Cells were collected for analysis by collagenase digestion of whole liver tissue.  
Following mechanical deconstruction, liver samples were incubated for a minimum of 1 
hour in a 37°C water bath with shaking.  Supernatant was then strained and diluted to a 
per-sample volume of 40 mL with culture media.  Lymphocytes were isolated by 
centrifugation over Percoll density gradients. 
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Flow Cytometry  
Hepatic mononuclear cells were FcgR blocked using 2.4G2 antibody (ATCC) and 
stained with combinations of the following mouse conjugated mAb (all purchased from 
BioLegend): allophycocyanin (APC) or FITC anti-CD3, APC/Cy7 anti-CD4, PE anti-
CD8a, APC or PE anti-CD11c, PE or APC/Cy7 anti-I-A/I-E, APC/Cy7 anti-Ly6G, APC 
or APC/Cy7 anti-Ly6C, APC/Cy7 anti-Ly-6G/Ly6C (Gr-1), PE, FITC or Brilliant Violet 
421 anti-CD11b, APC or PE anti-F4/80. In addition, PE anti-Siglec-F (BD Biosciences) 
was used to stain eosinophils. Flow cytometric acquisition was performed on a FACSAria 
II (BD Biosciences) by 4-color analysis using FACSDiVa software and FlowJo, with a 
minimum of 50,000 live, single-cell events per sample collected.  
 
Statistical Analysis  
Data were analyzed using GraphPad Prism 5.0 (GraphPad, La Jolla, CA). Results 
involving two variables were analyzed by two-way ANOVA with a Bonferroni post-hoc 
test. Data comparing two groups were analyzed using an unpaired t test. Figures show 
combined data from multiple studies or independent repeats (two or more). Data shown are 
mean ± SEM. A p value < 0.05 was considered statistically significant. Significance 






Our laboratory has previously reported that the number and properties of NK cells 
are altered in IP-/- mice. Given that large numbers of memory NK cells are typically found 
in the liver, it was logical to characterize hepatic NK cells in IP-/- mice.  
 
Analysis of IP-/- hepatic NK cells by flow cytometry  
To detail the phenotype of hepatic NK cells, livers from wildtype C57BL/6 mice 
and IP-/- mice (C57BL/6 background) were dispersed using collagenase.  The resulting 
cell suspension was fractionated using Percoll density gradient centrifugation, and 
mononuclear cells collected for analysis. Cytometry revealed an abundance of hepatic 
lymphocytes in IP-/- mice compared to WT mice, particularly NK cells.  IP-/- mice had 
seven times more mononuclear cells than WT C57BL/6 mice.  Of the lymphocytes 
collected, 5.8% were DX5+NK1.1+ NK cells in IP-/- mice, whereas only 1.2% were 
identified as DX5+NK1.1+ in WT mice (Fig. A1).  This change in the proportion of NK 
phenotypes may indicate a defect in nonspecific immune reactivity in the absence of 
functional IP-prostacyclin signaling. Deficiency in the IP receptor also resulted in higher 
levels of NKp46 expression by NK cells evidenced by IP-/- hepatic MNC being 7.6% 
NK1.1+NKp46+ compared to 0.3% in C57BL/6 (Fig. A1)., i.e., IP-/- mice possessed more 
than 20 times as many hepatic NKp46+NK1.1+ NK cells as WT mice.   
 
Analysis of IFNγ production by splenic and hepatic NK cells in IP-/- mice  
IFNγ is the predominant cytokine produce produced by NK cells. In order to 
investigate the functional properties of hepatic NK cells in the IP-/- and C57BL/6 mice 
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hepatic MNC were cultured overnight on plates pre-coated with either anti-NK1.1 (20 
µg/mL) or PBS in the presence of exogenous IL-2 (10 pg/mL) and the level of IFNγ present 
in culture supernatants assayed by ELISA. Positive controls consisted of hepatic MNC that 
were cultured in the presence of immobilized anti-CD3 (2 µg/mL) in order to activate 
resident T cells.  Controls comprised cells cultured in media of different concentrations of 
α-galactosylceramide (Gal-cer, a ligand for NK-T cells which are known to produce IFNγ). 
Curiously, although NK cells were present in hepatic MNC preparation, activation using 
immobilized NK1.1 did not induce IFNγ production above what was observed in media 
alone, even with the addition of Gal-cer. Interestingly, stimulation of hepatic MNC with 
immobilized anti-CD3 did induce the production of large amounts of IFNγ; however, 
C57BL/6 cells produced markedly more cytokine than did cells from IP-/- mice (Fig. A2) 
with levels reaching only one fifth of the IFNγ produced by WT cells. These findings were 
in marked contrast to the production of IFNγ by NK cells in the spleens, since application 





NK1.1 and DX5 (CD49b) are prototypic NK cell surface markers. The former is an 
allotypic marker expressed by NK cells in C57BL/6 mice, while DX5 is a NK cell marker 
of particular utility as it is expressed by all mouse strains.  We observed increased 
expression of NKp46 by CD3-CD19- cells that expressed NK1.1, signifying an expanded 
population of NK cells in the livers of IP-/- mice compared to wildtype mice.  NKp46 is 
one of the natural cytotoxicity receptors (NCR) commonly expressed by both activated and 
non-activated NK cells.  Recognition by this receptor typically results in immediate 
degranulation of the NK cell and lysis of the activating target cell (179).  While this might 
be expected to be associated with increased NK cell cytotoxicity, it has recently been 
discovered that the immunomodulatory capacity of NKp46+ NK cells is critical to defense 
against certain inflammatory disorders in the liver.  The progression of nonalcoholic fatty 
liver disease is determined in large part by the activation of Kupffer cells, liver-resident 
macrophages which respond to the release of damage-associated molecular patterns from 
damaged hepatocytes by recruiting inflammatory monocytes to the liver tissue.  NKp46+ 
NK cells are able to hamper this inflammatory response by polarizing liver macrophages 
toward a wound-healing and anti-inflammatory M1 phenotype by secreting IFNγ.  Hepatic 
inflammation is significantly exacerbated and prolonged in the absence of NKp46+ NK 
cells and ultimately results in fibrosis (180).  
 A major problem encountered in this study was that the production of IFNγ in 
response to NK1.1 cross-linking by both IP-/- and WT NK cells was minimal. The reason 
for this lack of response remains unclear and conceivably could be an artifact associated 
with the use of collagenase to release MNC from the liver tissues. In contrast, stimulation 
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of cultured hepatic MNC with anti-CD3 antibody did induce cytokine production; hepatic 
T cells from IP-deficient mice still produced substantially less IFNγ than did NK derived 
from wildtype mice.  The reason for this marked reduction in the IFNγ response likely 
reflects a reduction in the number of T cells producing this cytokine. These findings 
indicate that prostacyclin-IP signaling plays a pivotal role in the maturation of hepatic T 


















Figure A1: Hepatic DX5+NKp46+NK1.1+ NK cells are more abundant in IP-/- mice.  
Livers from IP-/- and C57BL/6 mice were dispersed using collagenase and the number and 
characteristics of the NK cells present evaluated by flow cytometry. 
Flow cytometry revealed that hepatic DX5+NK1.1+ NK cells make up 5.8% of cells 
present in IP-/- mice compared to only 1.2% present in wildtype mice. In addition, the level 





Figure A2: IFNγ production in response to anti-CD3 is reduced in hepatic MNC from 
IP-/- mice.  
Hepatic MNC from C57BL/6 and IP-/- mice were cultured in the presence of plate-bound 
anti-NK1.1 with 10 ng/mL IL-2 (20 µg/mL) or anti-CD3 (2 µg/mL) for 24h. Supernatants 
were assayed for IFNγ revealed by ELISA. Hepatic MNC from C57BL/6 produced 
significantly higher levels of IFNγ than IP-/- cells following anti-CD3 activation (300 pg 






Figure A3: IFNγ production by splenic MNC in response of anti-NK1.1. 
Spleens cells were stimulated on plates pre-coated with anti-NK1.1 and exogenous IL-2 
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Background: Epidemiological studies suggests that prenatal and early life environmental 
exposures have adverse effects on pulmonary function and are important contributors in 
the development of childhood asthma and allergic disease. The mechanism by which 
environmental tobacco smoke (ETS) exposure in utero promotes the development of 
allergic asthma remains unclear. In this study, we investigated the immunological 
consequences of prenatal exposure to ETS in order to understand events responsible for the 
development or exacerbation of allergic asthma.  
Methods: Pregnant C57BL/6 mice were exposed to ETS or filtered air throughout 
gestation and the effects on pulmonary inflammation in the offspring were examined and 
compared. Specifically, the effects on eosinophilic inflammation, airway hyperreactivity, 
goblet cell hyperplasia, properties of pulmonary natural killer (NK) cells and type 2 
cytokines elicited in response to inhaled house dust mite (HDM) allergen were investigated 
in the progeny. 
Results: Exposure to ETS prenatally significantly exacerbated HDM-induced airway 
eosinophilic inflammation, hyperreactivity, mucus secretion, cysteinyl leukotriene 
biosynthesis and type 2 cytokine production in the offspring. Consistently, lung 
mononuclear cells from ETS-exposed offspring secreted higher levels of IL-13 when 
stimulated in vitro with anti-αβ TCR antibody or HDM allergen. Moreover, offspring from 
ETS-exposed dams exhibited a higher frequency of CD11b+ dendritic cells and CD3+CD4+ 
T lymphocytes in the lungs following allergen inhalation compared to air-exposed mice. 
Unexpectedly, the exacerbated allergic inflammation in the ETS-exposed offspring was 
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associated with a reduction in CD3-CD19-NK1.1+CD94+ NK cell numbers and their IFN-
γ production, highlighting a role for innate immunity in the enhanced allergic response.  
Conclusion: Our results reveal that prenatal exposure to ETS predisposes offspring to an 
exacerbated allergic airway inflammation that is associated with a reduction in pulmonary 
NK cell function, suggesting that NK cells play a key role in controlling asthma severity.   
 
Keywords: Prenatal exposure, Environmental tobacco smoke, Allergic asthma, Innate 
immunity 
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